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Summary 
Metabolomics is defined as the systematic analysis of hundreds or thousands of small 
metabolites present in a living system. It has emerge as an important field of study along with 
other, already established ‘omics’ sciences, i.e., genomics, proteomics and transcriptomics. 
Metabolomics is well established in the field of medicine, drug toxicity and disease diagnosis. 
Among the existing analytical techniques, NMR is a fast, reproducible and non-destructive 
technique to construct an informative snapshot of the metabolites under certain conditions. NMR 
data give metabolic signature information of the samples when it is combined with data 
preprocessing and chemometric tools, such as multivariate statistical techniques. NMR-based 
metabolomics is still expanding in the field of the food chemistry. In this context, this Ph.D. 
thesis is focused on two major aspects, which show applications of NMR-based metabolomics in 
food chemistry. 
1. Many nutraceutical products possess powerful antioxidant activity as demonstrated in many 
chemical in vitro tests and in several in vivo trials. Nevertheless, the mechanism of their activity 
is not completely studied in detail. Due to their poor bioavailability and fast metabolism, studies 
on the in vivo antioxidant effects are still needed. We performed longitudinal experiments on 
Sprague Dawley (SD) rats using two commonly available nutraceutical antioxidant products, 
namely, Curcumin (chapter 2) and Resveratrol (chapter 3). The effects of different doses of 
orally administered standardized antioxidant extracts in healthy rats were investigated by 
untargeted metabolomic analysis based on LC-MS and NMR spectrometry. The experiments 
were carried out over different periods of time for different antioxidants. Changes in the urinary 
metabolome were evaluated by monitoring the 24-hour urine composition by 1H-NMR and 
HPLC-MS. The two different approaches were able to detect variations in the urinary levels of 
antioxidant markers, leading to the observation of different metabolites thus proving the 
complementarity of these two analytical techniques for metabolomic purposes. Analytical tools 
such as MS and NMR spectroscopy in combination with chemometrics can profile the impact of 
time, stress, nutritional status, and environmental perturbations on hundreds of metabolites 
simultaneously. This results in complex, massive data sets that must be analyzed through a 
careful statistical protocol. Our strategy included data preprocessing, data analysis and validation 
of statistical models. After several data processing steps, principal component analysis (PCA) 
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and partial least-squares (PLS) were used to identify urine biomarkers. The PLS models were 
validated by permutation tests and critically important variables were validated through 
univariate analysis. 
2. The second part of this thesis (chapters 4 and 5) describe the use of NMR-based metabolomics 
as a fast, convenient, and effective tool for origin discrimination and biomarker discovery in food 
analysis. Traditionally, the determination of the floral origin of honey is made from 
palynological analysis. The method is based on the identification of pollen by microscopic 
inspection. However, melissopalynological analysis needs expertise and also it is not a very 
reliable technique for the discrimination of botanical origin of some types of honey. Also, honey 
regulation in the EU (Codex Alimentarius Commission 2001; European Commission 2002) 
emphasizes that the botanical and geographical origins of the product must be printed on the 
label in order to avoid the fraud such as adulteration with industrial sugar, selling product under 
false name or mixing the honey of different floral origin. Therefore, there is need to establish a 
method to discriminate honey from different origin. The aim of this work was to develop an 
NMR-based metabolomic approach that used multivariate statistical analysis to discriminate the 
botanical (chapter 4) and entomological (chapter 5) origin of different types of honey. 
Multivariate statistical analysis helped us to identify the most relevant signals to differentiate 
honey botanically and entomologically. The obtained data sets were useful in the search of 
markers responsible for the discrimination of different honey samples from different botanical 
species and produced by different bee species. 
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Sommario 
La metabolomica è definita come l'analisi sistematica di centinaia o migliaia di piccoli metaboliti 
presenti in un sistema vivente. È emerso come un importante campo di studio insieme ad altre, 
già affermate scienze "omiche", vale a dire, genomica, proteomica e trascrittomica. La 
metabolomica è ben consolidata nel campo della medicina, nello studio della tossicità di farmaci 
e nella diagnostica. Tra le tecniche analitiche esistenti, NMR è veloce, riproducibile e non 
distruttiva, utile per fornire una fotografia informativa sui metaboliti in determinate condizioni. 
Dati NMR forniscono informazioni metaboliche che caratterizzano i campioni quando  
combinati con una pre-elaborazione dei dati e con strumenti chemiometrici, come le tecniche di 
statistica multivariata. La metabolomica basata sull’NMR è ancora in espansione nel campo della 
chimica degli alimenti. In questo contesto, questa tesi di Dottorato si concentra su due aspetti 
principali, che mostrano applicazioni della metabolomica basata sull’NMR in chimica degli 
alimenti. 
1. Molti prodotti nutraceutici possiedono potente attività antiossidante, come dimostrato in molti 
test chimici in vitro e in diverse prove in vivo. Tuttavia, il meccanismo della loro attività non è 
completamente studiato in dettaglio. A causa della loro scarsa biodisponibilità e metabolismo 
veloce, sono ancora necessari studi in vivo sugli effetti antiossidanti. Abbiamo condotto 
esperimenti longitudinali su ratti Sprague Dawley (SD) utilizzando due prodotti antiossidanti 
nutraceutici comunemente disponibili, vale a dire, curcumina (capitolo 2) e resveratrolo (capitolo 
3). Gli effetti di diverse dosi di estratti antiossidanti standardizzati somministrati per via orale nei 
ratti sani sono stati studiati mediante analisi metabolomica non mirata (untargeted) basata su LC-
MS e spettrometria NMR. Gli esperimenti sono stati eseguiti lungo diversi periodi di tempo per 
diversi antiossidanti. Le variazioni del metaboloma urinario sono state valutate attraverso il 
monitoraggio della composizione delle urine di 24 ore usando 1H-NMR e HPLC-MS. I due 
differenti approcci sono stati in grado di rilevare le variazioni dei livelli urinari di marcatori 
antiossidanti, portando all’osservazione di diversi metaboliti e dimostrando così la 
complementarità di queste due tecniche analitiche per scopi metabolomici. Strumenti di analisi 
come la spettroscopia NMR e MS in combinazione con chemiometria possono delineare 
l'impatto del tempo, dello stress, dello stato nutrizionale, e di perturbazioni ambientali su 
centinaia di metaboliti contemporaneamente. Ciò comporta complessi enormi set di dati che 
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devono essere analizzati mediante un protocollo statistico accurato. La nostra strategia ha 
compreso una pre-elaborazione dei dati, l’analisi dei dati e la validazione dei modelli statistici. 
Dopo varie fasi di elaborazione di dati, l’analisi delle componenti principali (PCA) e l’analisi dei 
minimi quadrati parziali (PLS) sono state utilizzate per identificare i biomarcatori urinari. I 
modelli PLS sono stati convalidati dai test di permutazione e le variabili di importanza critica 
sono stati convalidati attraverso analisi univariata. 
2. La seconda parte di questa tesi (capitoli 4 e 5) descrivono l'uso di metabolomica basata su 
NMR come strumento veloce, conveniente ed efficace per la discriminazione di origine e la 
scoperta di biomarcatori in analisi degli alimenti. Tradizionalmente, la determinazione 
dell'origine floreale del miele è  condotta mediante analisi palinologica. Il metodo si basa sulla 
individuazione di polline mediante ispezione microscopica. Tuttavia, l'analisi 
melissopalinologica richiede perizia ed inoltre non è una tecnica molto affidabile per la 
discriminazione di origine botanica di alcuni titpi di miele. Inoltre, la regolamentazione del miele 
nell'Unione Europea (Codex Alimentarius 2001; Commissione Europea 2002) sottolinea che le 
origini botaniche e geografiche del prodotto devono essere stampate sull'etichetta, per evitare 
frodi, come l'adulterazione con zucchero industriale, vendita di prodotti sotto falso nome o 
aggiunte di miele di diversa origine floreale. Pertanto, vi è la necessità di stabilire un metodo per 
distinguere miele di diverse origini. Lo scopo di questo lavoro è stato quello di sviluppare un 
approccio metabolomico basato sull’NMR che ha utilizzato l'analisi statistica multivariata per 
discriminare l'origine botanica (capitolo 4) ed entomologica (capitolo 5) di diversi tipi di miele. 
statistica multivariata ci ha aiutato ad identificare i segnali più importanti per differenziare il 
miele sia dal punto di vista botanico che entomologico. I set di dati ottenuti sono stati utili nella 
ricerca di marcatori responsabili della discriminazione dei diversi campioni di miele di diverse 
specie botaniche e prodotti da diverse specie di api. 
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Outline of the thesis 
This PhD thesis is divided into five chapters. 
Chapter 1 discusses the concepts and terms used in the field of metabolomics. Also, it 
emphasizes the basic principles of NMR and its application in food metabolomics with some 
literature examples. Finally, the chapter ends with the definition and role of chemometrics in 
metabolomics and some specific aspects of chemometrics in NMR-based metabolomics. 
Chapter 2 deals with the application of NMR-based metabolomics to assess the in vivo effect of 
nutraceuticals containing antioxidants on rat urine. Specifically, curcumin was used in a high 
dose in a longitudinal experiment in which urine was collected over a seven week period. An 
untargeted MS and NMR-based metabolomic approach was used to identify markers of oxidative 
stress in rat urine. 
Chapter 3 shows the continuation of our study on the extract of Polygonum cuspidatum, a source 
of resveratrol, an antioxidant also found in red wines or in other foods of the Mediterranean diet. 
The aim of the work was to analyze the in vivo effect of resveratrol on rat urine, again using 
NMR and Mass spectrometry-based metabolomics. 
Chapter 4 covers the application of NMR-based metabolomics in the field of food quality 
assurance; specifically, we used honey as a food matrix. The aim of the work was to use NMR as 
an analytical tool to differentiate citrus honey from clementine honey, two products deriving 
from very similar plants. 
Chapter 5 describes the role of NMR-based metabolomics in combination of chemometrics to 
discriminate the entomological origin of Equador honey. It also dicusses the authentication of 
genuine honey and its differentiation from fake honey with a simple liquid-liquid chloroform 
extraction. 
Chapter 6 briefly summarizes the finding of the research describes in this thesis.  
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Chapter 1: General Introduction 
1.1 Metabolomics in Systems Biology 
Cellular metabolites are the final outcome of the response of biological systems to genetic 
changes, stress or other environmental influence. The study of their concentration is therefore 
central to understand biological systems and to characterize different physiological and 
pathological conditions [1]. In the last twenty years, the technological progress in the field of 
biological sciences made it possible to analyze complete sets of genes (genomics), mRNA 
(transcriptomics), proteins (proteomics) and metabolites (metabolomics) rather than to study 
single genes, single mRNA, single proteins or single metabolites in a living system. While other 
“omics” sciences are very well established, metabolomics is still in its growing stages. The 
detailed investigations of the entire ‘‘omics cascade’’, from genomics to transcriptomics to 
proteomics to metabolomics will play a vital role in the field of systems biology [2, 8]. Figure 
1.1 shows how the process of information is successfully passed on from genes to metabolites in 
a living system. [1, 2] 
 
Figure 1.1: The “omics” cascade  
1.2 Metabolomics 
Metabolomics is the endpoint of the ‘‘omics cascade’’ as shown in the Figure 1.1 and is the 
closest to the phenotype, which gives metabolomics the advantage to serve as a direct signature 
of biochemical activity and earned it the description of “the apogee of omics” [3]. The term 
metabolome was first used by Oliver [2] as the set of low-molecular-mass compounds 
synthesized by an organism. A few years later, the term metabolomics was introduced by Fiehn 
in 2001 as “the identification and quantification of every single metabolite presents in a 
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biological system” [4]. Before this in 1999s, the term metabonomics was used by J. K. Nicholson 
and colleagues as follows: “the quantitative measurement of the time related multi-parametric 
metabolic response of living systems to pathophysiological stimuli or genetic modification” [5].  
There has been some conflict over the exact differences between the two terms, metabolomics 
and metabonomics. This difference is mainly philosophical, rather than technical; although there 
are some differences in concept, in practice, the analytical and modeling procedures are the same 
and the two terms are often used interchangeably [6]. The term metabolomics will be used in this 
thesis throughout to cover in vivo study of anti-oxidants compounds in rat urine and honey origin 
discrimination. 
Metabolomics attempts to systematically identify and quantifies metabolites from biological 
samples. The small molecules characterize the end result of complexity of biological processes in 
a given cell, tissue or organ and thus form attractive candidates to understand disease phenotypes 
as shown in Figure 1.2. Metabolites represent a diverse group of low-molecular weight 
structures including lipids, amino acids, peptides, nucleic acids and organic acids, which makes 
comprehensive analysis a difficult analytical challenge [7]. 
 
Figure 1.2: Complexity of Metabolome. 
Metabolomics has been growing rapidly since its inception in the late 2000’s (Figure 1.3) and the 
increasing number of papers published in the field of metabolomics makes it an emerging tool to 
study changes in phenotype under different biological conditions.  
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Figure 1.3: PubMed search result of the number of publications with “metabolomics” as a key 
word.  
1.3 Approaches in Metabolites Analysis 
Currently, four complementary approaches are used for metabolomic investigations: Metabolic 
profiling, Metabolic fingerprinting, Metabolite target analysis and Metabolomics [1, 8]. A 
summary of metabolomics-related definitions are depicted in Figure 1.4.  
Fiehn [1] gave the first detailed definition of metabolomics and its subsections: (1) Metabolite 
target analysis, aims at quantitative analysis of substrate and/or product metabolites of a target 
protein; (2) metabolic profiling, aims to quantify a pre-defined set of metabolites belonging to a 
class of compounds or members of particular pathways or a linked group of metabolites; (3) 
metabolomics, attempts an unbiased overview of whole-cell metabolic patterns. For a more rapid 
analysis, (4) metabolic fingerprinting can be used, which reduces the analytical effort to the 
analysis of these intra-cellular metabolites with biochemical relevance [8, 9]. 
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Figure 1.4: Different approaches used in metabolomics. 
1.4 Analytical Platforms Used in Metabolomics 
Metabolomics aims at the comprehensive and quantitative analysis of wide arrays of metabolites 
in biological samples. These numerous analytes have diverse physical-chemical properties and 
occur at different abundance. Consequently, comprehensive metabolomic investigations are 
primarily a challenge for analytical chemistry [9]. From the beginning, a variety of different 
analytical platforms have been used for metabolomics. Among them are thin-layer 
chromatography (TLC) [10], infrared spectroscopy (IR) [92], near infrared (NIR) [93], gas 
chromatography (GC) [12], nuclear magnetic resonance (NMR) [13, 14], high-performance 
liquid chromatography (HPLC) [14], mass spectrometry (MS) by direct-infusion [15] or coupled 
to chromatographic techniques, such as GC [16, 17], capillary electrophoresis (CE) [18] and 
liquid chromatography [19-20]. Among these different analytical techniques and tools used 
within metabolomics, Mass Spectrometry (MS) and NMR spectroscopy are the most popular and 
can profile the impact of time, stress, nutritional status, and environmental perturbation on 
hundreds of metabolites simultaneously resulting in massive, complex data sets [8, 21-22]. 
Figure 1.5 shows a typical metabolomic workflow for an untargeted metabolomic study. This 
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strategy starts with the processing of the spectral data to generate the sample metabolic 
information. Different analytical techniques, such as NMR or MS, can be used to acquire the 
data. The main focus of this thesis is NMR-based metabolomics and its applications in food 
chemistry, as described in detail in the next section. Once the complete set of metabolomic 
features has been produced, multivariate data analysis methods are applied to investigate the 
general structure of the metabolomic data and how the different metabolic features are related 
with the phenotypic data associated with the samples. Finally, significant metabolites observed 
are identified with the help of online databases and their biological interpretation in biological 
system discussed [23]. 
 
Figure 1.5: Analytical workflow in metabolomics and different steps involved. [23] 
1.5 Nuclear Magnetic Spectroscopy 
NMR, with the help of other complementary spectroscopic techniques, such as Infrared (IR), 
Ultraviolet (UV) and MS, is generally used to determine an organic compound’s unique 
structure. In this section,   1H-NMR spectroscopy will be briefly described.  
Many atomic nuclei have a property called spin. Nuclei that possess either odd mass or odd 
atomic number or both have a quantized spin angular momentum and a magnetic moment. The 
magnetic moment (µ) is directly proportional to the angular momentum (P): µ =γP, where γ, the 
gyromagnetic ratio, is a constant for each nucleus. Each nucleus with spin has a nuclear spin 
quantum number, I, which determines the allowed spin states. For each nucleus, I is a physical 
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constant, and there are 2I+1 allowed spin states with integral differences ranging from +I to –I. 
Nuclei with I = 0 cannot be seen in NMR. In the absence of an external applied magnetic field, 
the nuclear spins are oriented in random directions as shown in Figure 1.6(A). As a result the 
samples do not have any macroscopic magnetization. When an external magnetic field (B0) is 
applied, the nuclei align themselves either with or against the field of the external magnet, as in 
Figure 1.6(B). [24]. 
 
Figure 1.6 (A-B): (A) Nuclei in the absence of a magnetic field, the individual nuclear magnetic 
moments; (B) In the presence of an applied magnetic field, the nuclear magnetic moments are 
aligned with the applied field. 
For I = ½ nuclei, two spin states are possible: one at lower energy, called , and one at higher 
energy, called  (Figure 1.7). The nuclear magnetic resonance phenomenon takes place when 
nuclei aligned with an applied magnetic field absorb energy and change state according to the 
direction of the applied magnetic field. 
 
Figure 1.7: The spin state of the proton in the absence and in the presence of magnetic field. 
 7 
The magnitude of the energy difference between the two spin states depends on the applied 
magnetic field. As shown by the Figure 1.7, the greater the strength of the applied magnetic 
field, the larger the energy difference. Therefore, the magnitude of the energy level separation is 
directly proportional to the applied magnetic field B0 and to the particular nucleus involved, 
according to its γ. The energy difference between the two states is equal to ΔE = γ (h/2π) B0 [25]. 
The difference in spin population between the  and the  state determines the magnitude of a 
bulk magnetization vector created by the alignment of nuclear spins along the B0 magnetic field 
(Figure 1.8). 
. 
Figure 1.8: Macroscopic magnetization resulting from the sum of individual nuclear magnetic 
moments. 
Application of an orthogonal energy pulse in the form of radio frequency (RF) imposes a torque 
on the bulk magnetisation vector in a direction that is perpendicular to the direction of the field 
(the ’motor rule’) which rotates the vector from the z-axis toward the x-y plane (Figure 1.9).The 
bulk vector will precess (rotate) about the central Z axis, defined by the direction of the B0 
magnetic field, at a frequency that depends not only on the strength of the applied magnetic field 
and that nucleus’ specific gyromagnetic ratio, γ, but also on the neighborhood and chemical 
environment of the nucleus under observation. The magnitude of these bulk magnetization 
vectors represents the number of nuclei under the influence of the magnetic field. The frequency 
of precession is called the Larmor frequency (ω0) and is defined as ω0 = γB0. 
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Figure 1.9. An RF pulse applies a torque to the bulk magnetization vector and drives it toward 
the x-y plane from equilibrium [26]. 
After the radiofrequency (RF) field is switched off, the system will return to equilibrium. 
Consequently, the readable magnetization in the xy plane decays to zero in a certain time during 
which a signal is recorded by the spectrometer in the form of a free induction decay (FID). 
During an NMR experiment, the signal is measured in the time domain, i.e., as a function of 
time, and, then, Fourier transformed to obtain the spectrum in the frequency domain. Thereby, 
the FIDs from active NMR nuclei in a sample, which superimpose in the time domain, are sorted 
out according to their Larmor frequency by the Fourier transformation [26]. Figure 1.10 A 
schematic diagram of the main components of an NMR spectrometer. 
 
Figure 1.10: A schematic diagram of the main components of an NMR spectrometer. 
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1.6 NMR-based Metabolomics 
Different techniques have their own strengths and weakness, resulting in different coverage of 
metabolomics.  Therefore, suitable choice of instrumentation is important to address specific 
questions in metabolomic analysis. The selection of proper instrumentation depends on the 
availability of these analytical platforms and on the possibility to combine different techniques to 
obtain a comprehensive metabolic profile. NMR is a powerful spectroscopic method, 
traditionally used as a very important tool in chemistry for structure verification, elucidation and 
purity analysis [27]. Sensitivity of NMR has always been a concern compared to MS, which has 
also developed better protocols for separating the components in a complex mixtures. 
Nonetheless, NMR spectra can be recorded and quantified more easily. The spectral complexity 
of the MS fragments can complicate the quantification process of ions or metabolites, and MS 
can identify only a small fraction of the metabolome. NMR is a robust and reliable technique for 
metabolomic applications, in which high reproducibility is paramount [28-29]. It allows the 
detection of a wide range of structurally diverse metabolites simultaneously, providing a 
metabolic ‘snapshot’ at a particular time point [30]. NMR spectroscopy is therefore a powerful 
complementary technique for the identification and quantitative analysis of metabolites either in 
vivo or in tissue extracts and biological fluids [28]. The sensitivity issue of NMR has decreased 
recently with advancement in NMR spectrometer hardware such as used of cryoprobes, cold-
probes or by using high field instruments, i.e., 800 MHz. Using high field instruments enhances 
both the sensitivity and resolution, but cost of the instrumentation is still an issue [31].  
In 2013, Wishart and colleagues introduced the Human Metabolome Database (HMDB) using 6 
different analytical platforms: NMR; GC-MS; DFI/LC-MS/MS; HPLC/UV; HPLC/FD and ICP-
MS. Today, the HMDB is the largest and most comprehensive, organism-specific metabolomics 
database [32]. It provides information on the composition of human biological fluids, along with 
custom-derived spectral libraries and targeted assays. In the case of urine, 445 distinct 
metabolites were identified and 378 quantified distinct metabolites. NMR spectroscopy was able 
to identify and quantify 209 compounds, as depicted in Figure 1.11, which shows that 1H-NMR 
has the potential to detect and identify a large number of compounds; as such, it is emerging as a 
leading technique in the area of metabolomic studies [12-13, 21-22]. 
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Figure 1.11: Venn diagram showing the broad range of NMR in comparison to other analytical 
techniques used in urine metabolomics [32]. 
Compared with MS, NMR spectroscopy yields relatively low-sensitivity measurements, with 
limits of detection on the order of 10 μM or a few nmol at high fields using new cryoprobes. 
Nevertheless, NMR has several prominent advantages over MS; for instance, biofluids can be 
analyzed without or with minimal sample preparation; also, NMR is highly quantitative and 
reproducible. Moreover, NMR is fast, convenient, and effective in discriminating between 
groups of related samples and it identifies the most important regions of the spectrum for further 
analysis [28]. These properties are especially important when metabolomic data are analyzed by 
multivariate statistical methods [33]. Compared with other techniques, NMR-based 
metabolomics is becoming a useful tool in the study of body fluids and has a strong potential to 
be particularly useful for the noninvasive diagnosis of different diseases [21], different types of 
cancer [34], diabetes [35], inborn error metabolism [36], kidney disorders [37] and also in early 
diagnosis of disease [22].   
There are two different approaches used in NMR-based metabolomics, depending on the aim and 
the information required from the experiment. In cases when the interest is limited to certain 
defined set of metabolites, the approach of choice is usually known as “targeted metabolomics”; 
in other instances, it may be of interest to examine as many metabolites as possible by using an 
“untargeted” approach [3]. 
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1.6.1 NMR-based Targeted Metabolomics 
Targeted metabolomic approaches are usually initiated by a specific biochemical theory or 
hypothesis that encourages the investigation of a particular pathway [3]. The aim of NMR-based 
targeted metabolomics is to quantitate several selected metabolites, typically few to hundreds of 
known compounds. This involves the ability to differentiate the targeted analytes from other 
intrusive compounds, which may be achieved based on chemical shift in an NMR spectrum [38]. 
Conventionally, quantitative analysis by NMR has been restricted to relatively simple mixtures 
with minimal peak overlap. In this context, 1D 1H-NMR is a natural choice, because its peaks 
scale linearly with concentration and its analytical precision is usually independent of the 
chemical properties of target molecules [20]. 1H-NMR provides spectroscopic fingerprints in 
which the spectral intensity distribution is determined by the relative concentrations of solutes, 
and in some cases by their intermolecular interactions. This approach is generally useful, for 
example, for pharmacokinetic studies of drug metabolism as well as for the study of the activity 
of specific enzymes under the influence of therapeutics or subject of genetic modification [40]. 
The same experimental and statistical standards apply to a targeted metabolomics approach as to 
any quantitative biological analysis. In order to obtain meaningful results, multiple biological 
replicates must be analyzed and subjected to appropriate statistical tests to establish the 
significant changes in metabolite concentrations between groups [41].  
1.6.2 NMR-based Untargeted Metabolomics 
The untargeted approach in metabolomics is the comprehensive analysis of all the measurable 
metabolite in a biological sample, including unknown chemicals. Due to its comprehensive 
nature, untargeted metabolomics must be coupled to advanced chemometric techniques, such as 
multivariate analysis, to reduce the large datasets generated into a smaller set of manageable 
variables [41]. The nature of many compounds of interest in untargeted metabolomics is 
unknown, hence several solvents and extraction methods should be applied and compared 
between the groups of samples [42]. The aim of the untargeted metabolomics is to measure the 
many metabolites as possible from biological sample in unbiased fashion. This unbiased 
approach make it global in scope and sometime is also known as global metabolite profiling [3]. 
Chapters 2 and 3 of this thesis are examples of untargeted metabolomic approaches; thus, more 
detail will be discussed later in chapters 2 and 3. 
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1.6.3 NMR-based Metabolomics in Food Chemistry 
Today, the need to ascertain and certify the quality of food is increasing because of increasing 
demand from industry and consumers. To improve and monitor the quality of our food, new 
tools and methods need to be developed. Metabolomics is a new technology with the potential to 
become one such tool of major value in this field. Phytochemicals cover a large proportion of the 
food metabolome. Some of the popular phytochemicals, such as lycopene in tomatoes, 
isoflavones in soy, proanthocyanidins in cranberries and polyphenols in fruits or in nutraceutical 
products, are responsible not only for the organoleptic properties, such as flavors and aromas of 
the plants, but also for their health properties [43-45]. Specifically, phytochemicals are rarely 
absorbed and excreted in their ingested forms; rather, they are extensively metabolized in the 
body. Therefore, only a limited portion of the theoretical 200,000 structures of phytochemicals 
have been characterized, suggesting that many remain to be discovered [44]. Metabolomic tools 
have become the method of choice and are being applied to the analysis of food components, the 
identification of their metabolites in body fluids and biological tissues, the evaluation of their 
bioavailability and metabolism, the role of gut microflora, and the physiological response to a 
particular diet regimen, food, or nutraceutical product [46-47]. The metabolic compositions of 
various biofluids reflect their diverse biological purposes and the functional integrity of the 
organs that are communicating with them, and eventually with the physiological status of the 
whole organism. NMR-based metabolomics has been employed extensively for multivariate 
metabolic profiling of cells, tissues and biological fluids [48-49]. Biofluids such as urine are very 
complex matrices containing a large number of potential biomarkers that can report on changes 
of endogenous metabolites in response to xenobiotic exposure [49-50]. Urine is a very popular 
biofluid for metabolomic investigations due to non-invasive collection, the complex metabolic 
nature of the fluid, and the ability to collect multiple samples over a period of time. The 
detection of metabolites and the information gained by tracing metabolic fluxes provides 
information regarding an organism’s physiological response following an environmental insult or 
the pathophysiology of a disease [51-52]. 
Based on the metabolomics approach, 1H-NMR screening has rapidly expanded in recent years 
in the area of food quality control i.e. food processing, quality, and safety. Advances in 
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compound extraction, separation, detection, identification, and data analysis enabled 
metabolomic reliable platform in the field of food sciences [45, 94]. NMR based metabolomic 
techniques assess the impact of food quality control in a reproducible manner for example 
adulteration of oranges juices with grape-fruit make it difficult for consumer to assess even via 
taste or aroma whether the juices are adulterated or not. Analysis of this kind of juice blending 
with HPLC-MS analysis is lengthy and labor process whereas, NMR-based metabolomic take 
less than half time as compare to chromatographic approach [53].  
The quality or origin of food matrices is mostly determined by its biochemical composition, i.e., 
its biochemical, metabolic profile [55]. Recently, NMR-based metabolomics coupled with 
chemometric analysis has been applied to obtain metabolic profiles of various kinds of food 
including honey [56-57], olive oil [58-59], meat [55, 60] salmon [61], milk [62], wine [63, 64], 
apple [65], mango [66], Italian sweet cherries [67], wheat [68],  and other plants [69-70]. Despite 
the considerable amount of reviews and articles published in the field of food metabolomic, 
applications of metabolomics in food and nutrition research are still scarce. The main 
contribution of this thesis is to show the application of NMR-based metabolomics in food 
chemistry. The next section of the thesis will briefly introduce the role and application of 
chemometrics in metabolomics. 
1.7 Chemometrics in Metabolomics 
Chemometrics was first introduced by Svante Wold in 1972. Further progress was made by 
Isenhour and Jurs when they published the first pattern recognition article in 1972. However, 
first real article on chemometrics was published by Kowalski, Massart and Wold [71]. 
Chemometrics is rather new, but it has a huge impact on the spectroscopic field as we know it 
today, to such an extent that chemometric software is currently integrated with laboratory and 
process instrumentation as a standard. Chemometrics is still developing and the definition may 
have to be modified or improvised from time to time in order to include all new developments 
[72]. In the 1980s, John demonstrated the use of chemometrics (multivariate data analysis) in 
combination with NMR spectroscopy. Later on, further advancement and potential was put 
forward by Nicholson and his group in the field of NMR-based metabolomics [5, 74].  
The overwhelming size and complexity of the ‘omics’ technologies has driven biology toward 
the adoption of chemometric methods. Extensive use of chemometrics in NMR-based 
14 
 
metabolomics first became computationally practical with the introduction of data-reduction 
methods such as the integration of spectral variables (preprocessing of data) into a limited 
number of regions, a technique that both reduces the computational time required to calculate 
models, and helps soften the effect of shifting resonances in NMR [74]. Therefore, it is necessary 
to perform some data reduction or preprocessing of any large data prior to transport the data for 
Multivariate data analysis (MDA). A typical workflow of chemometric analysis of NMR-based 
metabolomic data is shown in Figure 1.12. 
 
Figure 1.12: A typical chemometric workflow in an NMR-based metabolomic approach. 
1.7.1 Data Preprocessing 
Pre-treatment of raw spectral data is critical for generating reliable, interpretable models using 
multivariate analysis techniques. Data preprocessing is an intermediate step between raw spectra 
and data analysis. The main objective of data preprocessing is to transform the data in such a 
way that the samples in the dataset are more comparable in order to ease and improve data 
analysis. For NMR spectra, preprocessing usually involves: baseline correction, alignment, 
binning, normalization and scaling. Several reviews discuss the procedures involved for 
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preprocessing of metabolomics datasets, and efforts have been made to standardize the processes 
[75].  
1.7.1.1 Baseline Correction 
Generally, the first step of data preprocessing is the baseline removal. Baseline distortions in 1D 
NMR spectra are mostly due to the corruption of the first few data points in the FID (free 
induction decay). These corrupted data points add low frequency modulations in the Fourier-
transformed spectrum, giving rise to a distorted baseline [76]. Correction of these distortions is a 
necessary step in NMR spectra data processing because they offset the intensity values and result 
in inaccuracy in peak assignment and quantification. In turn, this affect not only the statistical 
analysis but also the quantification of the metabolites. These distortions can be corrected in many 
different ways; usually, an automated baseline correction is applied. In this thesis, all the NMR 
spectra were processed with manual baseline correction, performed with the ACD/LAB NMR 
software. In urine metabolomics, the entire region between 0.2-10.0 ppm is frequently used to 
see the effects of endogenous metabolites belonging to different classes. Although solvent 
suppression techniques are used to reduce the signal of water, the residual water signal might 
interfere with data analysis. For this reason, the region of the spectrum between 4.7 ppm and 5.0 
ppm is excluded from further data processing. 
1.7.1.2 Alignment 
Chemical and physical parameters such as ionic strength, concentration of some earth alkali, pH, 
and overall dilution of the urine influence the chemical shift of the 1H-NMR spectra, although 
not all the peaks are affected to the same extent. The resulting chemical shift variations, as large 
as 0.1 ppm, generate misalignments of homogeneous peaks, artifacts and misinterpretations [77]. 
One of the most annoying problems with NMR profiles, from a multivariate data analysis point 
of view, is the presence of peak shifts among different spectra. Therefore, an essential step in 
preprocessing should be careful adjustment of the peaks shifts, i.e., alignment. Usually, NMR 
spectra are first aligned by spectral referencing. This simple, global method for peak alignment 
sets the internal reference signal of each spectrum to 0.0 for TSP (as an internal standard) or 7.27 
ppm (CD3Cl) for the residual non-deuterated solvent. Nonetheless, this global method is not 
sufficient to overcome the problem of alignment [78]. Various methods have been reported so far 
[79] for the alignment of NMR spectra. In chapter 2 of this thesis, we used the Cluster-based 
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Peak Alignment (CluPA), a recent method for aligning NMR spectra, proposed by Vu et al [80]. 
The algorithm builds a hierarchical cluster tree from peaks of reference and target spectra and it 
aligns two spectra using this tree [80]. Although algorithms used for peak alignment might solve 
one problem, they can alter peak areas. Therefore, it is necessary to analyze unaligned spectra for 
the absolute biomarker quantification [81]. A representative example of an aligned 1H-NMR 
spectrum is given in Figure 1.13.  
 
Figure 1.13: Example of peak position variation: unaligned 1H-NMR citric acid peaks (Upper 
panel) and profiles processed by CluPA (lower panel). 
1.7.1.3 Binning 
In order to reduce the data dimensionality, binning (also called bucketing) is commonly used. 
The binning procedure helps in filtering noisy spectra, masks elusive chemical shift differences, 
and it also hides potentially significant changes of low-intensity peaks nearby strong signals. 
Among the many types of spectral binning available, the most commonly used one is an 
equidistant binning of 0.04 ppm: every spectrum is divided into evenly spaced integral regions 
with spectral width of 0.04 ppm [83]. This equal size binning suffers from lack of flexibility of 
the boundaries. For instance, if a peak is split between two bins, this may significantly influence 
the data analysis. In order to avoid peaks being split by the boundaries of bins, methods which 
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are based on non-equidistant spacing have been proposed, e.g., adaptive-intelligent binning, 
Gaussian binning, adaptive binning using wavelet transform and dynamic adaptive binning [81]. 
1.7.1.4 Scaling and Normalization 
Another important preprocessing step for NMR spectra of metabolomic studies is scaling and 
normalization. However, it should be noted that normalization and scaling operations offer 
different purposes and in fact, in usual practice it is also possible to use a combination of 
normalization and scaling methods [83]. The normalization steps are performed to account for 
variations of the overall concentrations of samples caused by different dilutions. Particularly for 
urine, unintended variations of the overall concentrations of samples are very distinctive. The 
dilution of human and animal urine can arise from food deprivation or drug effects and can 
exceed a factor of 10 [85]. Being the biological collection of waste material, urines reflect large 
variability in metabolite concentrations within control subjects. Therefore, data normalization 
and scaling between variables is typically applied to remove unwanted systematic variations 
meanwhile retaining the interesting biological information. Other inter-sample variations, such as 
different relaxation times or variations in RF pulse calibration, can be corrected by 
normalization. Normalization also involves measurement of urinary volumes and animal weights 
as a study proceeds. [82, 85]. A number of methods for normalizing metabolite profiles has been 
reported and every method is based on certain assumptions as to the nature of the data [83]. 
Some of the most common normalizations methods are: (1) Integral normalization; the simplest 
form of normalization, also called constant-sum normalization, whereby each spectrum is 
normalized such that its global integral is 1. While this accounts for variable dilutions each 
sample may possess, it can cover truly biologically relevant changes and obscure interpretation 
of loadings [75]; (2) probabilistic quotient/median fold-change [84]; (3) a reference feature 
present in all samples at a constant level. Normalization may be accomplished internally by 
computational means using internal standards (e.g., TSP) [86] (4) The use of Creatinine peak for 
normalization is also a common practice in urine metabolomics under the assumption that it 
scales well with muscle mass [95].  
The variation in metabolite levels is often linked to concentration in such a way that higher 
concentration metabolites have higher variation. This variation has a strong impact on the 
multivariate statistical analysis. Therefore, it is essential to scale metabolite intensities before 
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analysis to prevent selection of the most abundant metabolites as significant contributors. A 
number of scaling methods are commonly used, namely, mean centering, autoscaling, Pareto 
scaling, range scaling [81].  
Mean centering is used to adjust the differences between high- and low-concentration 
metabolites by converting all values to vary around zero instead of around the mean of the 
metabolite level. Mean centering is commonly used in combination with other scaling methods. 
In case of autoscaling, all metabolites are subjected to unit variance and therefore the data is 
analyzed based on the correlations instead of covariances. Autoscaling is sensitive to noisy data, 
and noisy variables tend to be overvalued. Pareto scaling is widely used in metabolomics since it 
is an intermediate option. It uses the square root of the standard deviation as the scaling factor 
instead of the standard deviation. This scaling method is sensitive to large changes in the data but 
keeps closer to the real data. Range scaling uses the difference between the minimal and the 
maximal concentration of each metabolite which makes all metabolites in the data equally 
important. However, it is important to keep in mind that range scaling is sensitive to outliers 
because only two values are used to calculate the range. [75, 81-82]  
1.7.2 Multivariate Statistical Analysis 
The first step in Multivariate statistical analysis (MVA) is to perform an unsupervised analysis, 
which occurs without prior knowledge of neither the nature nor the group membership of the 
samples. This is often performed using principal component analysis (PCA) [87]. Data have to 
be preprocessed or “cleaned” before this exploratory treatment. 
1.7.2.1 Principal Component Analysis: 
PCA is the most common statistical analysis tool in metabolomics [73], invented by Pearson in 
1901 [88] and later on rediscovered by Wold [89]. Hotelling further developed PCA to its 
present shape [87]. PCA is a multivariate analysis based on projection methods used for 
dimension reduction of data. It is an unsupervised technique and is used in chemometrics as 
workhorse to extract and display the systematic variations in the data. A PCA model provides a 
summary, or overview, of all observations or the samples in the data table. PCA converts the 
multidimensional data space into a low dimensional model plane that approximates all rows 
(e.g., objects or observations) in X, that is, the group of points. This technique expresses most of 
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the variance within a data set using a smaller number of factors, called Principal Components 
(PCs) (tpT) as depicted in Figure 1.14. The first PCA model component (t1p1
T) describes the 
largest variation in the swarm of points. The second component models the second largest 
variation and so on. Each PC is a linear combination of the original variables; thus, each 
successive PC explains the maximum amount of variance, which was not accounted for the 
previous PCs. Each PC is orthogonal to the other PCs and therefore exhibits different 
information. The variation in spectral data is described by a few PCs, compared to the number of 
original variables. Moreover, it enables to find trends, groupings, and extend outliers in the data 
[73, 81, 89]. Mathematically, PCA can be written as follows:  
X =TPT + E = t1p1
T + t2p2
T +……… E 
Where X is the data matrix representing samples and variables decomposed into a score matrix 
(T) and a transposed loading matrix (PT). The E matrix represents the residuals, the part of the 
data not ‘explained’ by the PC model [89]. There are two important matrices obtained from the 
PCA model, known as score and loading plot (Figure 1.14).  
 
Figure 1.14: A representation of a Principal Component Analysis Model showing the reduction 
of data into score and loading plot [73]. 
In a score plot, each point represents a single spectrum. It provides a summary of all spectra and 
shows how they are related to each other. If the observations are close to each other, it means 
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they are similar whereas, observation far from each other are dissimilar. The loadings describe 
the way in which the old variables are linearly combined to generate new variables (PCs) and 
indicate which variables have the greatest contribution in transforming to the new variables. 
Thus, any spectral clustering observed in the score plot is interpreted by examination of the 
loadings. This is a powerful tool for understanding the underlying patterns in the data [73, 81]. 
1.7.2.2 Partial Least Square (PLS) Analysis 
Unlike PCA, PLS is a supervised method, commonly used in metabolomics. Metabonomic 
studies typically include sets of controls and treated samples. In these situations, a more focused 
evaluation and analysis of the data is possible. The basic principle is similar to PCA, but in PLS, 
a second piece of information is used, namely, the labeled set of class identities. In addition to an 
X-matrix of observations (e.g., spectra/samples) and variables (bins) that is used in PCA, a Y-
matrix is created that consists of the same observations but the variables are classes, e.g., treated 
or controls [90]. This enables the establishment of a linear model that can predict Y from the 
measured spectra in X. Observations belonging to the class have a value of one and observations 
not belonging to the class have a value of zero. Like PCA, PLS regression generates a linear 
model of the data, but where PCA models the principal variations in the data itself, PLS derives a 
model that describes the correlation between the X variables and a feature (Y variable) of interest 
[73]. 
PLS can also be used in discriminant analysis, that is, PLS-DA. The Y matrix then contains 
qualitative values, for example, class belonging, gender, and treatment of the samples. OPLS 
can, analogously to PLS-DA, be used for discrimination (OPLS-DA) [91]. In Figure 1.15, the 
advantages with OPLS-DA compared to PLS-DA are described. The between-class variation and 
the within-class variation are separated by OPLS-DA but not by PLS-DA, and this facilitates the 
OPLS-DA model interpretation [73].  
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Figure 1.15: A geometrical illustration of the difference between the PLS-DA and OPLS-DA 
models. In the left panel, the PLS components cannot separate the between-class variation from 
the within-class variation [73]. 
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Chapter 2. New findings on the in vivo antioxidant activity of Curcuma longa 
extract by an integrated 1H NMR and HPLC–MS metabolomic approach. 
This chapter is taken from the following article:  Stefano Dall’Acqua, Matteo Stocchero, Irene 
Boschiero, Mariano Schiavon, Samuel Golob, Jalal Uddin, Dario Voinovich, Stefano Mammi, Elisabetta 
Schievano ‘New findings on the in vivo antioxidant activity of Curcuma longa extract by an 
integrated 1H NMR and HPLC-MS metabolomic approach’, published in Fitoterapia 2016, 109, 
125-131. 
 
2.1 Abstract 
Curcuminoids possess powerful antioxidant activity as demonstrated in many chemical in vitro 
tests and in several in vivo trials. Nevertheless, the mechanism of this activity is not completely 
elucidated and studies on the in vivo antioxidant effects are still needed. Metabolomics may be 
used as an attractive approach for such studies and in this paper, we describe the effects of oral 
administration of a Curcuma longa L. extract (150 mg/kg of total curcuminoids) to 12 healthy 
rats with particular attention to urinary markers of oxidative stress. The experiment was carried 
out over 33 days and changes in the 24-h urine samples metabolome were evaluated by 1H NMR 
and HPLC–MS. Both techniques produced similar representations for the collected samples 
confirming our previous study. Modifications of the urinary metabolome lead to the observation 
of different variables proving the complementarity of 1H NMR and HPLC–MS for metabolomic 
purposes. The urinary levels of allantoin, m-tyrosine, 8-hydroxy-2′-deoxyguanosine, and 
nitrotyrosine were decreased in the treated group thus supporting an in vivo antioxidant effect of 
the oral administration of Curcuma extract to healthy rats. On the other hand, urinary TMAO 
levels were higher in the treated compared to the control group suggesting a role of curcumin 
supplementation on microbiota or on TMAO urinary excretion. Furthermore, the urinary levels 
of the sulphur containing compounds taurine and cystine were also changed suggesting a role for 
such constituents in the biochemical pathways involved in Curcuma extract bioactivity and 
indicating the need for further investigation on the complex role of antioxidant curcumin effects. 
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2.2 Introduction 
Food supplements and nutraceuticals are largely used for health promoting purposes mainly 
ascribed to the antioxidant properties of the phytochemicals contained in these products. 
Nevertheless, it is well accepted that the antioxidant activity is poorly related to the radical 
scavenging properties that can be demonstrated with in vitro chemical assays. Furthermore, 
studies related to the real in vivo antioxidant activities of these chemicals as well as to their 
effects on healthy subjects are still missing. In general, the study of in vivo antioxidant activity is 
difficult due to the complex multiple targets of purified natural products or extracts possessing 
this effect [1, 2]. Current studies of antioxidant phytochemicals are generally focused on specific 
compounds and their effects are evaluated on a limited number of markers [1].  
Curcuma longa L. is extensively used in Ayurveda, Unani, Siddha, and Chinese medicine for the 
management of various diseases. This spice is highly regarded for its numerous biological 
activities especially related to antioxidant, anti-inflammatory and cancer preventive properties 
[3–11]. The effects of C. longa are ascribed to the presence of diarylheptanoid compounds 
known as curcuminoids (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin), 
which are considered the main active principles of the plant, although their bioavailability is poor 
because of scarce absorption, rapid metabolism and systemic elimination [12, 13]. Extremely 
low serum levels of curcumin after oral administration were observed [12], making it difficult to 
explain its antioxidant properties on the basis of simple radical scavenging action. Nevertheless, 
extensive scientific research over the past decade [6, 14–17] has shown that this compound is 
able to modulate multiple cellular targets and hence that it possesses preventive and therapeutic 
value against a wide variety of diseases thus showing the need for new approaches in the study 
of this natural product. Previous studies in rats have shown the ability of curcumin to upregulate 
the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2), which is responsible for 
phase 2 antioxidant and detoxification genes expression, indicating that this compound increases 
the total superoxide dismutase and glutathione peroxidase activities [18,19]. 
Metabolomics can offer new opportunities in this research area since it allows the observation of 
changes in particular bio-fluids caused by the overall effect of a natural product on different 
biochemical pathways. Urinary biomarkers of oxidative status present a great opportunity to 
study redox balance because specimen collection is non-invasive [20] and long-term observation 
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experiments are possible. Therefore, studies using urinary metabolome analysis are attractive 
especially for the evaluation of antioxidants in healthy subjects or in healthy in vivo models.  
In a previous study, we used a metabolomic approach to study the changes of the urinary 
metabolic profile after the administration of C. longa extract in rats. Compared to the control 
group, the treated animals were characterized by decreased levels of allantoin, a urinary 
biomarker of oxidative stress [21].  
As a continuation of our previous study, we evaluated the effect of oral daily administration of 
standardized Curcuma longa L. extract (corresponding to 150 mg/kg of total curcuminoids) to 12 
healthy rats by untargeted metabolomics. Treatment was carried out over 33 days and changes in 
the urinary metabolome were evaluated by monitoring the 24-h urine composition by 1H NMR 
and HPLC–MS. Urinary collections at 42 days (after stopping the treatment at day 33) were also 
analysed. We attempted to use the combined potential of NMR and MS in a unified metabolomic 
approach as a powerful tool to assess the modification of urine composition caused by curcumin 
supplementation in a healthy animal model. Both techniques produced similar representations for 
the collected samples confirming our previous study using similar methodology. The two 
different approaches were able to detect variations in the urinary metabolome, leading to the 
observation of different variables thus proving the complementarity of these two analytical 
techniques for metabolomic purposes. 
2.3 Experimental 
2.3.1 Materials 
Curcumin standard, methanol, acetonitrile, formic acid, hydrochloric acid, deuterated water, 
methanol, glutathione (GSH), sulphosalicylic acid (SSA), γ-glutamyl-glutamic acid (γ-Glu-Glu), 
ethylenediaminetetracetic acid (EDTA), and N-ethylmaleimide (NEM) were obtained from 
Sigma-Aldrich(Milan, Italy). Curcumin glucuronide was synthesized in our laboratory using a 
previously published protocol [22]. C. longa L. dried extract was purchased from a local market; 
the total curcuminoid content was measured as previously described [21,23] as 94%; specifically, 
71.0%, curcumin, 20.5% demethoxycurcumin, and 2.5% bisdemethoxycurcumin were 
determined using HPLC–MS and HPLC-DAD measurements [21]. 
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2.3.2 Animals and Urine Collection 
All experimental protocols involving animals were reviewed and approved by the Ethical 
Committee for animal experiments of the University of Padua (CEASA, protocol number 
49571). The study involved 12 Sprague–Dawley rats: 6 males and 6 females, 8 ± 1 weeks of age, 
at the beginning of the experiments; male animals weighted 78.0 ± 2.3 g and female animals 79.5 
± 4.0 g. They were caged in a temperature- and photoperiod-controlled (12-h light/dark cycle) 
room with rodent maintenance diet and water ad libitum. Rats were randomly divided into a 
control (three males and three females) and a curcumin-treated group (three males and three 
females). No differences were observed between the two groups at the beginning of the 
experiment, based on HPLC–MS and NMR preliminary data. Six hundred milligrammes of C. 
longa extract were suspended in 12 mL of water. The treated group received a daily dose of 160 
mg/kg of C. longa extract (corresponding to 150 mg/kg total curcuminoids or 112 mg/kg of 
curcumin) orally by gavage for 33 days. An equal dose of water was given to the control group. 
At day 0, 6, 15, 22, 28, 33 and 42 (10 days after the end of the treatment), the animals were 
housed individually in metabolic cages for the collection of the 24-h urine outputs. The collected 
samples were stored at −80 °C until 1H NMR and HPLC–MS analysis. 
2.3.3 HPLC–MS Urine Analysis 
The UPLC-HRMS analysis was conducted by the group of Prof. Stefano Dall’Acqua at the 
Department of Pharmaceutical Sciences, University of Padova.  To obtain a metabolic profiling 
of urine, an HPLC–MS full scan method was used. A Varian MS 500 equipped with a prostar 
430 autosampler and binary chromatograph 212 series (Varian, Palo Alto, USA), was used as 
HPLC–MS system. An Agilent (Milan, Italy) Eclipse XDB C-8 column (2.1 × 150 mm 3.5 μm) 
was used as stationary phase. The mobile phase was composed of solvent A (acetonitrile with 
0.5% acetic acid) and solvent B (water with 2% formic acid). Linear gradients of A and B were 
used, as follows: 0 min, 10% A; 20 min, 85% A; 21 min, 100% A, 21.30 min, 10% A; 27 min, 
10% A. The flow rate was 200 μL/min and the injection volume was 10 μL. The mass range 
explored was 50–1000 m/z. MS were recorded both in positive standard mode and in turbo 
depending data scanning (tdds) mode that allows the elucidation of the fragmentation patterns of 
the detected ions. Collected urine samples were centrifuged (13,000 g for 10 min) and directly 
injected in the HPLC. Each HPLC–MS data set was processed with MZmine 2.9 software [24]; 
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from the raw data files, we obtained a data set composed of 102 variables. Median Fold Change 
normalization was applied to take into account the effects of sample dilution. Data were log-
transformed and mean centred. 
2.3.4 1H–NMR Urine Analysis 
Aliquots of 700 μL of urine at pH 2.50 ± 0.05 were centrifuged at 13,000 rpm for 10 min and 
mixed with 70 μL of 2 mM 3-(trimethylsilyl)propionate-2,2,3,3,-d4 (TSP) in D2O solution. 1H 
NMR spectra were recorded at room temperature using a Bruker (Rheinstetten, Germany) 
Avance DMX 600 spectrometer. One-dimensional spectra were acquired using the 
NOESYGPPR1D pulse sequence. Parameters used were: 64 scans, 32 k data points, spectral 
width of 8389.26 Hz, 2 s relaxation delay, 50 ms mixing time, 1.95 s acquisition time. Prior to 
Fourier transformation, the FIDs were zero-filled to 64 k points and an exponential line 
broadening factor of 0.3 Hz was applied. All spectra were manually corrected for phase and 
baseline distortions using ACD/NMR Workbook software (Advanced Chemistry Development, 
Inc. Toronto, Ontario, Canada) and were referenced to the CH3 resonance of creatinine at 3.13 
ppm. Spectra were aligned using the CluPA algorithm (VU T.N., Laukens K., Valkenborg D. 
(2012) speaq: an R-package for NMR spectrum alignment and quantitation. R package version 
1.1.). The spectral region between 4.7 and 5.0 ppm was removed prior to statistical data analysis 
to avoid variability due to the residual water signal. Data were reduced to 470 bins by intelligent 
bucketing; the obtained data set was normalized by Total Sum Normalization and mean 
centering and Pareto scaling were applied. 
2.3.5 Blood Sample, Glutathione and Curcumin Quantification 
Whole blood samples were collected at day 34 and stored in heparinised tubes at −20 °C until 
analysis. GSH was measured using a previously described method [25]. Briefly, a 20 mM GSH 
stock solution in water was used to prepare calibration curves. The precipitating solution was 
prepared by mixing 150 μL of a solution containing NEM, EDTA and γ-Glu-Glu (in 
water/methanol, 85/15 (v/v)) with 50 μL of SSA; the final concentrations in the precipitating 
solution were 20 mM, 2 mM, 250 μM and 2% (w/v) for NEM, EDTA, γ-Glu-Glu and SSA, 
respectively. Curcumin was measured using a previously published method using SPE extraction 
[23]. 
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2.3.6 Statistical Data Analysis 
Multivariate data analysis based on projection methods was applied for statistical data analysis. 
Specifically, exploratory data analysis was performed by principal component analysis (PCA) 
while a new projection to latent structures (PLS)-based method was applied to study the changes 
in the urinary metabolome during the experiment. While PCA is a well-known technique used in 
multivariate data analysis [26], the PLS-based approach applied to model the data collected 
during our longitudinal study was recently published by our group [21]. Projection to latent 
structures by partial least squares regression (PLS) [27] is an effective and robust regression 
technique used to investigate the relationships existing between two blocks of data, usually 
called X- and Y-block. In metabolomics applications, PLS often produces a large number of 
latent components with the result to compromise a clear interpretation of the model. For this 
reason, we elaborated a post-transformation method, called post-transformation of PLS2, able to 
decompose the structured variation of the X-block discovered by PLS into two main blocks 
corresponding to the variations correlated (the so called parallel or predictive block) and 
orthogonal to the Y-block by a suitable rotation of the weights of the PLS model. Post-
transformation of PLS2 is a three step approach. In the first step, a PLS regression model is built 
on the data; in the second step, the weight matrix of the model is rotated while in the third step a 
regression model is rebuilt by using the same framework of the PLS algorithm but the new 
weight matrix to project the data. The relationships between the X-block and the Y-block can be 
investigated by exploring only the parallel part of the model by using suitable correlation loading 
plots. As a result, the model obtained by post-transformation of PLS2 maintains the same power 
in prediction and regression coefficients of the unrotated PLS model but can be easily interpreted 
because the number of components useful to interpret the model is usually reduced. Post-
transformation of PLS2 can be applied to model longitudinal studies by considering the 
experimental data and the design matrix as X- and Y-block, respectively. In our study, we 
supposed an interaction model to define the design matrix. The significance of the terms time, 
treatment and time× treatment included in the model was evaluated by permutation tests. 
To avoid over-fitting and prove the robustness of the obtained models, we performed N-fold full 
cross-validation with different values of N (N=6, 7, 8) and a permutation test on the response 
(500 random permutations) according to good practice for model validation. Data set comparison 
was performed by Bidirectional Orthogonal Projections to Latent Structures (O2PLS) [28]. PCA 
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and PLS models were built using SIMCA 13 (Umetrics, Umea, Sweden) while the platform R 
3.0.2 (R Foundation for Statistical Computing) was used to perform t-test and Mann–Whitney 
test, to post-transform the PLS model (user-written R function) and to build the O2PLS model 
(user-written R function). 
2.4 Results 
2.4.1 Animal Weight and Urinary Output 
No differences in the treated vs control group were observed in animal weight and 24-h urinary 
output during the experiment. The differences between the two groups were not statistically 
significant according to t-test and Mann-Whitney test (both p-values were >0.10). Data are 
summarized in Table 2.1. 
 Body weight (g) Urine volume (mL) 
Day Control Treated Control Treated 
0 78.8 ± 3.7 78.8 ± 3.1 6.3 ± 4.0 7.0 ± 2.4 
6 110.0 ± 5.0 107.6 ± 7.3 10.7 ± 3.0 15.3 ± 6.5 
15 190.3 ± 20.4 180.8 ± 20.8 12.7 ± 2.2 15.7 ± 5.3 
22 230.8 ± 38.1 217.0 ± 39.6 13.8 ± 2.0 16.5 ± 2.7 
28 254.8 ± 44.8 236.8 ± 45.1 11.2 ± 1.8 11.8 ± 2.1 
33 278.5 ± 60.8 262.8 ± 55.0 11.5 ± 1.5 10.6 ± 1.2 
42 300.3 ± 68.7 290.3 ± 64.0 10.0 ± 2.9 10.3 ± 3.1 
Table 2.1. Variations of body weight and 24-hour urine output of the rats during the course of 
the experiment. 
2.4.2 Data Analysis of the 1H NMR and HPLC–MS Data Sets 
Exploratory data analysis on the two data sets did not show the presence of outliers in the data. 
PCA models of the urines collected on day 0 did not show differences between rats belonging to 
the control or the treated group. 
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As a first step of our data modelling strategy, the two data sets were compared to investigate the 
common information shared by NMR and HPLC–MS. To this end, we scaled both data sets to 
unit variance and applied O2PLS (Fig. 2.1). The obtained model showed a joint overlapping 
variation described by 3 latent components (R2 = 0.59 for NMR and R2=0.45 for HPLC–MS), a 
unique systematic variation for NMR having 4 latent components (R2=0.19) and a unique 
systematic variation of 4 latent components for HPLC–MS (R2=0.29). As a consequence, we can 
conclude that a large part of the systematic variation of the two data sets contains the same 
information while only a small part is unique and non-overlapping in the two data sets. Figure 
2.1 shows the score scatter plot for the first and the second latent components describing the joint 
co-variation of the two data sets: the common information can be qualitatively interpreted in 
terms of the effects of time evolution and curcumin supplementation. This first model considers 
only the correlation structure existing between the NMR and the HPLC–MS data sets, and 
ignores the chemical identity of the variables used. For this reason, we cannot consider the two 
data sets as equivalent as will be proven with the following models. 
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Figure 2.1. Score scatter plot describing the joint systematic variation explained by the first and 
the second latent component of the O2PLS model; different symbols and colours were used to 
allow the interpretation of the observed patterns in terms of time evolution and treatment effect. 
C = control; T = treated; the numbers refer to the day of urine collection. 
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In the second part of our data modelling strategy, post-transformed PLS2 models of the data 
related to urine samples collected from day 6 to day 33 proved that the interaction term time × 
treatment was not significant at the level of 95% and that a simple linear model can be used for 
the design matrix. Both the model obtained for the 1H NMR data set and that obtained for the 
HPLC–MS data set clearly showed the effects of time and treatment on the metabolic profile of 
the urine as it can be observed in the score scatter plots of Figure 2.2 and 2.3. The model for the 
1H NMR data set had A = 2 + 4 components, R2 = 0.74 and Q2 = 0.52 for treatment and R2 = 
0.77 and Q2 = 0.70 for time while the model for the HPLC–MS data set had A = 2 + 2 
components, R2 = 0.73 and Q2 = 0.44 for treatment and R2 = 0.85 and Q2 = 0.64 for time. 
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Figure 2.2. 1H-NMR data set: score scatter plot for the post-transformed PLS2 model; the time 
evolution of the composition of the collected urines is described by the horizontal axis (tp[1]) 
while the vertical axis (tp[2]) represents the effects of the different treatment. C = control; T = 
treated; the numbers refer to the day of urine collection. 
By analyzing the correlation loading plots of the obtained models, it was possible to find 
variables characterizing the time evolution of the samples and the effects of curcumin 
administration on the rat urine metabolome. 
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Days 15, 28 and 33 were selected as key points of the experiment to check the presence of 
significant modifications of control vs. treated groups in the metabolites highlighted by our 
analysis. 
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Figure 2.3. HPLC-MS data set: score scatter plot for the post-transformed PLS2 model; the time 
evolution of the urinary metabolome can be observed along the horizontal axis (tp[1]) while the 
effects of the treatment are included in tp[2] (vertical axis). C = control; T = treated; the numbers 
refer to the day of urine collection. 
Considering the 1H NMR data, resonances associated with the discrimination between control 
and treated groups were observed in the range of deshielded protons (8.17–8.50 ppm), but it was 
not possible to assign any known metabolite to those signals (Figure 2.4). Tentative assignments 
were deduced on the basis of spectral data for bins as reported in Table 2.2. Hippuric acid, 2-
oxoglutarate and trimethylamine N-oxide (TMAO) levels were higher in the treated group 
compared to the control. On the other hand, the urinary marker of oxidative stress, 8-hydroxy-2′-
deoxyguanosine (8-OHdG), was higher in the control group. The correlation loading plot 
obtained for the model of the HPLC–MS data set highlighted significant differences in a set of 
variables that were chemically identified and are related to oxidative stress. Specifically, our 
untargeted approach confirmed the metabolites found in our previous targeted approach [21].  
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Figure 2.4. Representative 600 MHz 1H NMR spectra of urine after oral administration of 
curcumin in rats. (a) Aliphatic region (0.0–4.5 ppm). (b) Aromatic region (5.0–9.5 ppm). The 
vertical scale in the aromatic region was magnified four times compared with that in the aliphatic 
region. 
Indeed, four urinary markers of the oxidative status of the animals, i.e., allantoin, m-tyrosine, 3- 
nitrotyrosine, and 8-OHdG, were identified in the urine on the basis of their m/z value and 
fragmentation patterns compared to those registered in the Human Metabolome Database and 
Mass Bank Database. Furthermore, urinary levels of two sulphur containing compounds, namely 
taurine and cystine were modified during the experiment. In Table 2.3, the calculated reduction 
of these metabolites as average measured data of treated vs. control animals on days 15, 28 and 
33 are reported. Allantoin, 3-nitrotyrosine, m-tyrosine, and 8-OHdG levels were significantly 
decreased in the treated compared to the control group starting from day 6 of urine collection, 
and also at the end of the treatment (Table 2.3). Surprisingly, on day 28 the average m-tyrosine 
levels were higher (+13%) in the treated group. 
 
 43 
ppm Assignment day 15 day 28 day 33 
8.50-8.17 not assigned >C* >C# >C* 
7.57-7.55 hippuric acid >T# >T* >T# 
4.30 Creatinine >C# >C* >C* 
3.95 8-OHdG >C# >C* >C* 
3.32 not assigned >T* >T# >T# 
3.23-3.22 TMAO >T* >T* >T# 
3.19 2-oxoglutarate >T* >T# >T* 
2.81 Citrate >C# >T* >T* 
1.81-1.79 hydroxybutyrate >C* >C* >C# 
Table 2.2. Comparison of selected bins observed in the NMR data set; differences between 
treated and control group are reported in terms of increase or decrease of the NMR integral. *p-
value <0.10 for both t-test and Mann-Whitney test; #difference in the mean values, but not 
significant at the level of 90% for both t-test and Mann-Whitney test. 
On day 33, allantoin, m-tyrosine, and 8-OHdG reductions in the treated group compared to 
controls were significant (p-value b 0.10 for both t-test and Mann–Whitney test). Significant (p-
value b 0.10 for both t-test and Mann–Whitney test) changes were also observed for taurine 
(−24%) and cystine (−40%) in the treated group compared to controls (Table 2.3). The levels of 
these metabolites were measured also 10 days after the administration of Curcuma extract 
stopped (day 42). At this point (day 42) no significant differences in urinary composition were 
observed between treated and control groups showing that the observed changes were reversible 
with the interruption of curcumin extract administration. 
Assignment day 15 day 28 day 33 
allantoin -31.0* -16.0# -34.0* 
3-nitrotyrosine -23.0# -18.0# -27.0# 
m-tyrosine -0.2# +13.0# -20.0* 
8-OHdG -0.7# -19.0# -28.0* 
taurine -4.4# -26.0* -24.0* 
cystine -24.0# -29.0* -40.0* 
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Table 2.3. Oxidative stress urinary markers reduction in the treated group as a percentage of the 
value of the control group; *p-value <0.10 for both t-test and Mann-Whitney test, #difference in 
the mean values, but not significant at the level of 90% for both t-test and Mann-Whitney test. 
2.4.3 Whole Blood Glutathione (GSH) and Curcumin Levels  
Blood samples were collected at the end of the treatment (day 34) and GSH and curcumin levels 
were measured. We did not find any difference between the average concentration of whole 
blood GSH in the control and the treated group on day 34. Curcumin, curcumin glucuronide and 
curcumin sulphate were not detectable in either the treated or control groups. 
2.5 Discussion 
Food supplements and nutraceuticals with claimed antioxidant properties are enjoying a growing 
diffusion because of their health-promoting effects. Polyphenols are a large group of 
phytochemicals that present strong chemical antioxidant properties. Their health benefits are 
often claimed based on their antioxidant properties in vitro, but evidence for in vivo antioxidant 
effects is still limited since no validated in vivo biomarkers have been identified and no long-
term studies are available [1, 29–31]. Metabolomics offers new opportunities for the evaluation 
of in vivo antioxidant properties of complex mixtures such as natural products [32–34]. The 
study of urinary metabolome and urinary biomarkers of oxidative stress is attractive because 
sample collection is simple and non-invasive [20] and may lead to the observation of modified 
levels of metabolites that can be considered as a starting points for depicting new mechanisms of 
in vivo antioxidant activity. In this paper, we report significant changes in the urinary 
metabolome of healthy rats, orally treated with curcumin, compared to controls in data sets 
obtained both by NMR and HPLC–MS. These results confirm our previous findings obtained 
using a different experiment design: a lower dose of curcumin extract (80 mg/kg) was 
administered, and a targeted HPLC–MS approach was used, by selecting 25 metabolites in the 
urine chromatogram [21]. In the present work, we identified a larger number of metabolites that 
are related to curcumin supplementation in healthy rats. 
The metabolic changes revealed by NMR data are related to phenolic compound metabolism. 
Previously published papers reported increase in urinary hippuric acid levels after administration 
of fruit and polyphenol rich foods [35]. Other authors reported that the oral administration of the 
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flavonoid quercetin to rats, in an NMR-based metabolomic study, resulted in an increase in 
choline, creatinine, dimethylglycine, hippurate, taurine, and TMAO and in the reduction in 
acetate, alanine, and lactate [36]. These authors considered the general changes of such 
compounds as modification in osmolyte levels thus suggesting that these data may indicate 
improved glomerular or general renal function and correlated their observation in kidney 
osmolyte activity to the potential beneficial effects of quercetin on kidney function and 
hypertension [36]. Our data showed a higher level of creatinine and taurine in the control group. 
It is difficult to correlate the decreased urinary creatinine levels in the treated group with any 
biological meaning. On the contrary, the reduced urinary taurine levels, confirmed our previous 
observations [21] and other published papers that reported lowered taurine brain concentrations 
in curcumin-treated rats [37]. Taurine has been previously reported to decline in a number of 
tissues with advancing age and also in rats, the urinary levels were significantly reduced with 
ageing [38]. On the other hand, increased urinary taurine levels have been indicated as a specific 
marker of liver toxicity [37, 38]. Cystine levels were also significantly reduced on day 33, but 
this metabolite can also derive from cysteine modification during 24-h urine collection so that it 
is difficult to assess its meaning in this bio-fluid. 
TMAO is an oxidation product of trimethylamine (TMA), and both these compounds are 
products of choline metabolism. The methylamine pathway is a typical example of microbial–
mammalian co-metabolism and is well known that intestinal microbiota plays a role in the 
catabolism of choline in humans and rodents [39]. Dietary choline is converted in TMA by gut 
microbiota and TMA is mainly oxidized to TMAO [39-41]; thus, an increase of such metabolite 
may be related to the influence of the oral curcumin treatment on intestinal microbiota. There is 
strong interest in the evaluation of TMAO plasmatic or urinary levels due to various physio-
pathological functions that have been proposed for this compound. In fact, recent animal studies 
have shown a link between intestinal microbial metabolism of the choline moiety in dietary 
phosphatidylcholine and coronary diseases through the production of TMAO, considered as a 
proatherogenic compound. In humans, the production of TMAO from dietary 
phosphatidylcholine is dependent on metabolism by the intestinal microbiota. Furthermore, 
ingestion of different types of foods, such as eggs or fish, may influence TMAO plasma levels 
[41–43]. Other authors reported the ability of oral broad-spectrum antibiotics to temporarily 
suppress the production of TMAO suggesting that intestinal microorganisms participate in 
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phosphatidylcholine metabolism to form circulating and urinary TMAO [41, 44]. Increased 
plasma TMAO levels are associated with an increased risk of incidence of major adverse 
cardiovascular events [41, 44]. The role of TMAO appears to be complex but our data indicate 
that curcumin oral administration modifies the microbiota or influences the urinary excretion of 
this compound thus leading to changed urinary levels in the treated group. This result suggests a 
role of the intestinal microbial population in the mechanism of action of curcuminoids. Recently, 
the ability of curcumin supplementation to modulate colonic microbiota during colitis and colon 
cancer prevention was studied showing an increase in microbial diversity and restoration of 
colonic microbial composition to that observed in healthy WT animals compared to mouse 
model of IBD-associated colon cancer [45]. 
Urinary levels of some markers of oxidative stress were significantly reduced because of the 
treatment, as demonstrated by HPLC–MS results. Allantoin is considered a urinary marker of 
oxidative stress, because it is the predominant product of non-enzymatic oxidation of uric acid 
by many types of free radicals, and it is considered a valid biomarker of oxidative state 
especially in humans [20]. 
m-Tyrosine is considered a promising biomarker for oxidative damage to proteins [46]. The 
highly reactive hydroxyl radical oxidizes phenylalanine residues to o-tyrosine and m-tyrosine 
and increased levels of these metabolites are correlated to an increased ROS production from 
normal metabolic processes or from exposure to exogenous factors. Also reactive nitrogen 
species react readily with tyrosine and protein-associated tyrosine to form free 3-nitrotyrosine 
and protein associated 3-nitrotyrosine, respectively [47]. Urinary 3-nitrotyrosine is a potential 
biomarker that may reflect the enhanced generation of reactive nitrogen species and it has been 
proposed as a biomarker to detect changes in oxidative stress and to evaluate the efficacy of 
therapeutic interventions aimed at reducing oxidative stress [48]. 
Urinary 8-OHdG is considered a biomarker of generalized cellular oxidative stress because it is 
one of the predominant products of oxidized DNA repair [49]. Because it is fairly water-soluble, 
it will be excreted into the urine without being further metabolized and it is considered a stable 
end product of non-enzymatic DNA oxidation [20]. Therefore, increased urinary levels of 8-
OHdG could be correlated to an increase of oxidative DNA damage [20]. Our experiment 
showed significant reduction of some of these urinary markers of oxidative stress after 33 days 
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of treatment (see Table 2.3), suggesting an in vivo antioxidant effect of curcumin 
supplementation in the healthy rat. 
To have a further parameter related to the oxidative state of the animals at the end of the 
treatment, blood samples were collected on day 34 and GSH levels were measured. The average 
blood GSH levels showed no difference (t-test p-value b 0.01) between the control and the 
treated group. Other authors reported similar results in a study that evaluated the effect of 
curcumin and one analogue [bis-1,7- (2-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione] (BDMC-A) 
on carbon tetrachloride-induced hepatotoxicity in rats. Control and curcumin treated groups 
presented the same GSH values, while significant increase in plasma GSH levels was observed 
in the animals group treated with CCl4 and curcumin compared with the CCl4 treated ones [50]. 
However, a previous study reported a role for curcumin against GSH depletion-mediated 
mitochondrial dysfunction in vitro and in vivo [51]. Another study reported a significant effect of 
curcumin on GSH biosynthesis in alveolar epithelial cells [52]. Other researchers have 
considered that some of the most important effects of curcumin, such as the anticarcinogenic, 
antimutagenic, antioxidant and cytoprotective activities can be explained by its inhibitory effect 
on glutathione S-transferase (GST) [15]. The capacity of curcumin to protect rats from 
adriamicin (ADR) nephrotoxicity was demonstrated [53]. Curcumin protected against ADR-
induced renal injury by suppressing oxidative stress and increasing kidney glutathione content 
and glutathione peroxidase activity; nevertheless, in the same paper, kidney GSH levels of 
animals treated either with saline or curcumin were similar showing that curcumin treatment 
does not increase kidney GSH levels but can restore ADR induced GSH depletion. Our results 
indicate that curcumin supplementation does not increase blood GSH levels in healthy subject. 
Considering this result the low plasma concentration of curcumin due to its poor absorption, 
must be underlined. Previous studies have reported that, due to poor bio-availability, only traces 
of curcumin are detected in plasma after oral administration [12]. Also our data showed no 
detectable curcumin and curcumin conjugated metabolites in blood 24 h after the last 
administration (day 34) indicating rapid elimination of the compound from the bloodstream, in 
agreement with previously published results that reported the curcumin plasma peak 40 min after 
oral administration of 500 mg/kg in rats [54]. A large amount of orally administered curcumin, 
due to poor absorption, is present at the intestinal level so that the intestinal mucosa is exposed to 
higher concentrations of curcumin and for this reason, interactions of curcumin with GSH and 
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GST are likely to be more significant in intestinal epithelial cells rather than in plasma [55]. In 
our healthy animal model, curcumin supplementation is not likely to play a prominent role to 
change GSH levels in plasma. 
2.6 Conclusions 
In this work we used both 1H NMR and HPLC–MS techniques to study the modification of 
urinary composition in rats treated with C. longa extract correlated with in vivo antioxidant 
activity. Multivariate analysis on 1H NMR and HPLC–MS data produced similar representations 
for the collected samples. The two different approaches were able to detect variations in the 
urinary metabolome, leading to the observation of different components, showing the 
complementarity of these two analytical techniques for metabolomic purposes. The results of the 
present study are in agreement with our previously published data obtained with a lower 
curcumin dose and using a targeted 1H NMR and HPLC–MS approach [21]. The evaluation of 
the effects of Curcuma extract on urinary composition in healthy rats by a metabolomic approach 
led us to observe evidence for an in vivo antioxidant effect caused by a significant reduction in 
the amount of urinary biomarkers of oxidative stress such as allantoin, m-tyrosine, 8-OHdG. A 
tendency to the reduction of 3-nitrotyrosine was also observed. Our metabolomics-based study 
supports an in vivo antioxidant effect of the oral administration of C. longa extract to healthy 
rats. The observation that urinary TMAO levels are increased in the treated compared to the 
control group may be related to the influence of curcumin supplementation on microbiota, as 
recently indicated by other research groups, or on the urinary excretion of this metabolite. 
Urinary levels of taurine and cystine, sulphur containing compounds, were also changed 
suggesting a role for such constituents in the biochemical pathways involved in C. longa extract 
bioactivity and indicating the need for further investigation on curcumin effects. The 
undetectable plasmatic levels of curcumin and its conjugates confirmed its rapid elimination 
from the bloodstream after oral administration indicating that the contribution to the whole 
antioxidant activity by a direct radical scavenging action is negligible. The unchanged plasmatic 
GSH amount in treated and control group indicates that curcumin supplementation in the health 
subject does not increase this endogenous antioxidant's levels. 
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Chapter 3: Metabolic effects of Polygonum cuspidatum supplementation on 
urinary composition of healthy rats: a longitudinal study. 
3.1 Introduction 
Resveratrol (3,5,4’-trihydroxystilbene), is a simple polyphenolic compound that in the past 
twenty years has received widespread attention due to its supposed beneficial health effects. It is 
found in grapes, berries and peanuts [1] and in various plants, such as in Vitis vinifera and in 
Polygonum cuspidatum (Japanese knotweed). In traditional Chinese and Japanese medicine, P. 
cuspidatum has been used to treat several diseases such as hyperlipidemia, inflammation, 
infections and cancer [2]. P. cuspidatum is considered one of the best sources of resveratrol 
because it is a world-diffused invasive plant and it contains higher amounts of this compound 
than other plants or fruits [3]. This plant is also used as dried extract in the formulation of food 
supplements and herbal medicines, because of its content in resveratrol. 
Numerous resveratrol derivatives, such as piceid (resveratrol-3-O-β-glucoside) and other 
glucopyranoside-conjugates [2] have been detected in many botanical sources, but until now, 
only few studies have focused on their possible biological effects. 
Scientific interest in resveratrol has grown starting from the late 1990s, when it was first 
demonstrated to prevent carcinogenesis in mice [4]. Since then, its potential health promoting 
effects have been studied through numerous in vitro and in vivo experiments. A large number of 
pharmacological targets were discovered and numerous health benefits and disease-preventing 
activities, such as chemopreventive [5] and anti-inflammatory [6] ones, were related to 
resveratrol administration in animal models. Furthermore, many papers have considered 
resveratrol as a possible treatment or a preventing-agent with usefulness in cancer, 
cardiovascular disease, ischaemic injuries, as well as a possible enhancer of stress resistance. 
Finally, some papers considered this compound for its effects on the lifespan extension of 
various organisms from yeast to vertebrates [7-8]. Because of its antioxidant properties and its 
caloric restriction mimetic role [8], a prevention role in many age-related and metabolic diseases 
has been attributed to resveratrol, most importantly in obesity-related disorders such as diabetes 
and cardiovascular diseases [9-10]. 
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The mechanism by which resveratrol exerts such a range of beneficial effects is not yet clear. 
There are numerous papers describing in vitro and potential in vivo resveratrol effects, but doubts 
on its effectiveness are present because of its low bioavailability. Resveratrol is absorbed by the 
intestine but it is rapidly metabolized both in the intestinal lumen and in the liver in more 
hydrophilic derivatives that are then excreted in the urine as glucuronides and sulfates. 
Moreover, gut microbiota transform resveratrol in dihydroresveratrol by reducing the molecule's 
double bond and also this metabolite is absorbed by the intestine and further metabolized and 
conjugated [11]. Despite extremely low bioavailability and rapid clearance from the circulation, 
the evidence of health promoting effects of resveratrol in the prevention or delay of 
cardiovascular, metabolic and inflammation related diseases is growing [10]. 
One explanation can be that resveratrol may exert such different biological activities through 
multiple targets and multiple molecular mechanisms. Since several biochemical pathways are 
potentially affected, metabolomic approaches can provide unexplored information in the study of 
the bioactivity of natural products. The combined use of NMR and mass spectrometry coupled to 
liquid chromatography is a fast, effective and convenient tool to elucidate the alterations in 
metabolic pathways in biological fluids under different physiological conditions. Although mass 
spectrometry offers better sensitivity and better developed protocols, the use of NMR for the 
metabolic profiling of cells, tissues and biological fluids has grown extensively in the recent 
years [12]. 
The analysis of urinary metabolic changes can provide information on the effects of food 
supplements or health promoting products on healthy subjects or animal models. Specimen 
collection is non-invasive and long-term experiments can be easily conducted; some urinary 
biomarkers of oxidative stress can be measured offering the opportunity to evaluate the redox 
status of the considered organism [13]. Sample preparation is more straightforward in the case of 
urine than with other biological fluids (plasma for example) because of lower sample complexity 
and lower protein/peptide content [14]. Finally, urine samples the metabolic end-products from 
the organism destined for excretion; therefore, compared to blood, it is prone to higher biological 
variations [14]. Thus, the entire urine metabolome can be described by an untargeted approach 
and the subtle differences between control and treated groups can be highlighted by multivariate 
data analysis methods. 
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Food supplements and so called “nutraceutical” products are used by people with the aim to 
maintain or improve their state of health; nevertheless, scarce information is available in the 
published literature about the effects of these products on healthy animal models or subjects. In 
the case of resveratrol, many studies are available on its activity on pathological animal models, 
such as cancerous or diabetic rats or animals fed with a high-fat-diet [15-18], but no published 
papers deal with urine metabolomics of healthy animal models supplemented with P. cuspidatum 
extract.  
In the proceeding of metabolomics-based works on natural products performed by Dall’Acqua 
and collaborators [19-20], with the aim to evaluate the possible effects of P. cuspidatum on a 
healthy animal model, we supplemented rats with a P. cuspidatum extract (100 mg/kg containing 
20% of resveratrol) for 49 days. The variations of urinary composition were studied using 1H-
NMR, UPLC-HRMS and multivariate statistical analysis. Specific attention was devoted to two 
oxidative stress urinary biomarkers, namely allantoin and 8-hydroxydeoxyguanosine (8-OHdG). 
3.2 Experimental 
3.2.1 Materials 
P. cuspidatum extract was purchased from a local market. The resveratrol content was measured 
by HPLC-DAD and HPLC-MS analysis and the amount found was 20.0 ± 0.1% w/w. Allantoin, 
8-OHdG and resveratrol standards were purchased from Sigma Aldrich. HPLC-grade acetonitrile 
and formic acid were purchased from Sigma Aldrich. Deionized water used in HPLC and UPLC 
analysis was filtered through a Milli-Q system equipped with a 0.22 μm cut-off filter (Millipore). 
3.2.2 Experimental Design 
A longitudinal design was implemented to evaluate the effects of P. cuspidatum supplementation 
on the metabolite content of the urine collected during 49 days of treatment of 2 groups of rats. 
The treated group received, orally by gavage, a daily dose of 100 mg/kg of P. cuspidatum extract 
suspended in water while an equal dose of water was given to the control group. Rat urine 
samples were collected at day 0, 7, 14, 21, 28, 35 and 49 during the experiment and they were 
subjected to UPLC-HRMS and 1H-NMR analysis. The P. cuspidatum dose (100 mg/kg) was 
selected on the basis of the resveratrol content (20.0 ± 0.1% w/w corresponding to 20 mg/kg 
resveratrol), and considering previous published studies on rats showing both efficacy [21-23] 
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and safety of such oral dose [21]. 
All animal procedures were approved and conformed to the directives of the Ethical Committee 
for animal experiments of the University of Padova (CEASA). Six male and six female Sprague-
Dawley rats, 6 ±2 weeks of age and weighing 108.0 ± 24.4 g, where used for the study. Animals 
were fed standard laboratory diets and water ad libitum and were maintained in a temperature- 
and photoperiod- controlled room (12-h light/dark cycle). Rats were divided randomly in a P. 
cuspidatum treated group (three males and three females) and a control group (three males and 
three females). No differences were observed between control and treated groups at the 
beginning of the experiment on the basis of a preliminary metabolomics investigation.  
Rats were housed individually in metabolic cages for the collection of the 24-h urine outputs. 
Urine samples were then stored at -80 °C to avoid chemical degradation. 
3.2.3 UPLC-HRMS Urine Analysis 
The UPLC-HRMS analysis was conducted by the group of Prof. Stefano Dall’Acqua at the 
Department of Pharmaceutical Sciences, University of Padova.  To obtain a metabolic profile of 
urine, a UPLC-HRMS full-scan method was used. An Agilent 1290 Infinity UPLC system 
equipped with a Waters Xevo G2 Q-TOF mass spectrometer was employed. The detector was 
equipped with an electrospray (ESI) ionisation source and was operating in positive resolution 
mode. The sampling cone voltage was adjusted at 40 V, the source offset at 80 V. The capillary 
voltage was adjusted to 1500 V. The nebulizer gas used was N2 at a flow rate of 800 L/h. The 
desolvation temperature was 450 °C. The mass accuracy and reproducibility were maintained by 
infusing lockmass (leucine–enkephalin, m/z 556.2771) thorough Lockspray at a flow rate of 20 
μL/min. Centroided data were collected for each sample in the mass range 50 – 1200 Da, and the 
m/z value of all acquired spectra was automatically corrected during acquisition based on 
lockmass. An Agilent XDB C-8 column (2.1 mm x 150 mm, 3.5 μm) was used as stationary 
phase. The mobile phase was composed of solvent A (acetonitrile with 0.1% formic acid) and 
solvent B (water with 0.1% formic acid). Linear gradients of solvents A and B were used, as 
follows: 0 min, 8% A; 14 min, 48% A; 16 min, 100% A; 17 min, 100% A; 17.5 min, 8% A; 24 
min, 8% A. The flow rate was 200 μL/min and the injection volume was 1 μL. 
Collected urine samples were centrifuged at 13.000 rpm for 3 minutes prior to analysis and 
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directly injected in the UPLC. 
Centroided and integrated chromatographic mass data were processed by MarkerLynx 
Applications Manager Version 4.1 (Waters) to generate a multivariate data matrix. An 
appropriate method for data deconvolution, alignment and peak detection was created and the 
data were subsequently elaborated by the software. The parameters used were retention-time 
range 2.00–17.00 min, mass range 100–650 Da, mass tolerance 0.01 Da, noise elimination level 
was set to 10.00, minimum intensity was set to 15% of base peak intensity, maximum masses per 
RT was set to 6 and, finally, RT tolerance was set at 0.01 min. Isotopic peaks were excluded from 
analysis. A list of the ion intensities of each peak detected was generated, using retention time 
and the m/z data pairs as the identifier for each ion. The resulting three-dimensional matrix 
contains arbitrarily assigned peak index (retention time-m/z pairs), sample names (observations), 
and ion intensity information (variables). After the exclusion of the variables having more than 
30% of missing data in both groups under investigation and log-transformation, the obtained data 
set composed of 483 time x mass variables was normalized by Median Fold Change 
normalization and mean centred. 
3.2.4 1H-NMR Urine Analysis 
Sample preparation was performed as described elsewhere [24], with minor modifications. 
Frozen urine samples were thawed in a fuming hood for 30 min and then 1 mL urine was 
transferred into a 1.5 mL eppendorf vial. The pH value was adjusted to 1.2 ≤ pH ≤ 2 by adding 3 
M HCl (120 ± 80 µL) and the sample was centrifuged at 13,000 rpm for 10 min. To 700 µL of 
supernatant, 70 µL of 2 mM sodium 3-trimethylsilylpropionate-2,2,3,3,-d4 (TSP) in D2O were 
added. Finally, 700 µL were transferred into an NMR tube and the pH was monitored by 
inspection of the chemical shift of the citrate signal and sometimes adjusted by adding 5 µL of 1 
M NaOH or HCl. 2D-experiments were performed on a urine sample three times more 
concentrated, obtained by pooling several samples and partially evaporating the solvent.  
All 1H-NMR spectra were acquired on a Bruker Avance DMX600 MHz spectrometer equipped 
with a 5 mm TXI xyz gradient inverse probe at room temperature. The probe was tuned, matched 
and shimmed manually for each sample. The NOESYGPPR1D pulse sequence was used to 
acquire one-dimensional 1H-NMR spectra. Parameters used were: 64 scans; 32k data points; 
spectral width, 8389.26 Hz; relaxation delay, 2 s; mixing time, 50 ms; acquisition time, 1.95 s. 
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1H-1H NOESY spectra were recorded with the NOESYGPPRTP pulse sequence, with a spectral 
window of 13 ppm in both dimensions, 2048×512 data points, 1.2 s relaxation delay, 0.6 s 
mixing time, and 256 scans.  
Prior to Fourier transformation, the FIDs were zero-filled to 64K points and an exponential line 
broadening factor of 0.3 Hz was applied. All spectra were processed using ACD/NMR Manager 
12.01 (Advanced Chemistry Development Inc.). Spectra were referenced to 0.0 ppm using the 
resonance of TSP and manually corrected for phase and baseline distortions. Intelligent 
bucketing was applied to the region between 0.6 ppm and 9.5 ppm excluding the regions where 
resveratrol derivatives (6.24-7.50 ppm, 5.10-5.22 ppm, 4.10-4.26 ppm, 3.56-3.96 ppm, 2.74-2.82 
ppm) and water (4.70-4.95 ppm) resonate. Total sum normalization was applied to compensate 
for differences in overall concentration between individual urine samples. The obtained data set 
composed of 229 variables was mean centred and Pareto scaled. 
3.2.5 Statistical Data Analysis 
Data modelling was performed by applying multivariate techniques based on projection. 
Specifically, Principal Component Analysis (PCA) was used for exploratory data analysis and for 
highlighting the presence of outliers while Projection to Latent Structures by partial least squares 
regression (PLS) was applied to investigate the relationships between the metabolic content of 
the urines collected during the experiment and the time of treatment and type of diet. To perform 
an efficacy data modelling able to extract the whole information contained into the collected 
data, a design matrix supporting an interaction model including time, treatment and time x 
treatment effects, was explicitly considered. The measured variables and the design matrix were 
used as X-block and Y-block, respectively, in the PLS regression. Following good practice for 
model validation, N-fold full cross-validation with different values of N (N = 6, 7, 8) and 
permutation test on the responses (1000 random permutations) were performed, in order to avoid 
over-fitting and prove the robustness of the obtained models. The significance of the effects 
included in the design matrix was estimated by permutation test. The number of components of 
the PLS models was estimated on the basis of the first maximum of Q2 calculated by 7-fold full 
cross-validation (Q27-fold CV) under the constraint to pass the permutation test on the responses. To 
better interpret the obtained model, a new method for rotating the PLS model, called post-
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transformation of PLS2 (ptPLS2), was applied [25]. The main advantage to use the post-
transformation of the PLS model is the possibility to obtain a new model where the structured 
variation of the X-block discovered by PLS is decomposed into two blocks, corresponding to the 
variations correlated (predictive part of the model) and orthogonal (non-predictive part) to the Y-
block. The post-transformed model maintains the same power in prediction of the PLS model but 
simplifies model interpretation because the dimension of the predictive latent space is usually 
lower than that of the whole latent space discovered by PLS. 
Recently, stability selection was introduced in metabolomics to avoid false discoveries due to 
overtraining [26]. The central idea of stability selection is that real differences or effects should 
be present consistently, and therefore should be found even under perturbation of the data by 
subsampling or bootstrapping. In our study, we performed stability selection by Monte-Carlo 
subsampling using PLS VIP-based as regression technique [27] for identifying putative markers. 
Specifically, 200 random subsamples were extracted by Monte Carlo sampling of the collected 
urine samples (with prior probability of 0.70), and then PLS VIP-based applied to each 
subsample, obtaining a set of 200 regression models. Within this set of PLS VIP-based models, 
variables related to the effects of time and/or treatment were identified as the most frequently 
selected variables. The advantage to use PLS VIP-based is that the VIP selection is able to 
extract a reduced subset of variables for each subsample and the most frequently used variables 
can be selected by calculating the median of the VIP for each variable in all sub models 
excluding the variables having median equal to zero. The threshold of the VIP score to use in 
variable selection within PLS VIP-based was estimated by maximizing the Q27-fold CV. As a result, 
a small number of metabolites changing during the experiment was extracted and the behaviour 
of each single metabolite was studied by linear mixed-effects model for longitudinal studies [28]. 
In this step of our data analysis, the covariance structure was modelled by considering a first-
order autoregressive structure with homogenous variances. 
PCA was performed using SIMCA 13 (Umetrics, Umea, Sweden) while the platform R 3.0.2 (R 
Foundation for Statistical Computing) was used for statistical data analysis on single variable, to 
build the ptPLS2 model and to perform Monte-Carlo stability selection. 
The results of the levels of oxidative stress urinary markers are expressed as means ± Standard 
Error of the Mean (SEM). Statistical evaluation and p calculation were obtained using GraphPad 
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Prism 5 software (San Diego California). 
3.2.6 Urinary Allantoin and 8-Hydroxydeoxyguanosine Quantification 
Allantoin and 8-OHdG were quantified in urine samples from both treated and control rats using 
HPLC-MS/MS methods. A Varian 212 HPLC system equipped with a Varian MS 500 IT detector 
was used for HPLC-ion trap mass spectrometry. A Phenomenex Kinetex EVO C-18 column (3 
mm x 100 mm, 5 μm) was used as stationary phase. The detector was equipped with an ESI 
source and was operating in positive resolution mode. For allantoin quantification, the operating 
parameters used were as follows: nebulizing gas, nitrogen; nebulizing pressure, 35.0 psi; needle 
voltage, 4500 V; capillary voltage, 600.0 V; drying gas temperature, 350 °C; drying gas pressure, 
10.0 psi. The mobile phase was composed of solvent A (acetonitrile with 0.1% formic acid) and 
solvent B (water with 0.1% formic acid). Linear gradients of A and B were used, as follows: 0 
min, 15% A; 7 min, 100% A; 7.06 min, 15% A; 10 min, 15% A. The flow rate was 200 μL/min 
and the injection volume was 10 μL. An MSn experiment was performed, monitoring the 
fragmentation of allantoin precursor ion ([M+H]+, m/z 159) in the product ion mass range 65-169 
Da. Allantoin was finally quantified on the basis of its major fragment (m/z 116) using a standard 
titration curve obtained by eluting 0.3 - 1 μg/mL allantoin solutions in water (y = 97216x + 
51629; R2 = 0.9833). LOD and LOQ were 0.1 and 0.5 ng/mL, respectively.  
For 8-OHdG quantification, the operating parameters used were as follows: nebulizing gas, 
nitrogen; nebulizing pressure, 20.0 psi; needle voltage, 4500 V; capillary voltage, 600.0 V; 
drying gas temperature, 280 °C; drying gas pressure, 15.0 psi. The mobile phase was composed 
of solvent A (acetonitrile with 0.5% formic acid) and solvent B (water with 0.1% formic acid). 
Linear gradients of A and B were used, as follows: 0 min, 10% A; 1 min, 10% A; 10 min, 60% A; 
12 min, 10% A; 16 min, 10% A. The flow rate was 200 μL/min and the injection volume was 10 
μL. An MSn experiment was performed, monitoring the fragmentation of 8-OHdG precursor ion 
([M+H]+, m/z 284) in the product ion mass range 155-175 Da. 8-OHdG was finally quantified on 
the basis of its major fragment (m/z 168) using a standard titration curve obtained by eluting 3 - 
100 ng/mL 8-OHdG solutions in water (y = 48.853x + 1002.5; R2 = 0.9981). LOD and LOQ 
were 1 and 5 ng/mL, respectively.  
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3.3 Results 
3.3.1 Animal Weight and Urinary Output 
No significant differences were observed either in body weight or in 24-h urine volume in the 
treated vs control group during the experiment. Data reported in Table 3.1 show body weights 
and urinary volumes during the experiment. 
 Body weight (g) Urine volume (mL) 
Day Control Treated Control Treated 
0 108.5± 107.5± 5.5±0.7 6.4±1.4 
7 162.8± 164.8± 9.3±2.8 11.4±4.6 
14 205.8± 208.6± 12.3±3.7 10.1±1.8 
21 250.3± 248.0± 12.2±2.3 13.5±3.1 
28 283.8± 287.7± 10.8±1.4 13.4±1.8 
35 309.0± 303.5± 13.8±3.8 12.7±1.9 
49 332.0± 340.3± 15.8±8.0 12.9±1.9 
 
Table 3.1. Variations of body weight and 24-h urine volume of control and treated rats during the 
course of the experiment. 
 
3.3.2 UPLC-HRMS Measurements on 24-h Collected Urines 
Twenty four hour urine samples collected during the experiment were analysed by UPLC 
coupled with ESI-QTOF-MS to obtain urinary metabolite profiles of both treated and control 
animals. Exemplificative chromatograms are reported in Figure 3.1. Exploratory data analysis 
by PCA revealed no presence of outliers while PLS-DA did not detect differences in the 
metabolite content of the urines at day 0 between the two groups of rats. 
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Figure 3.1. Typical base peak intensity (BPI) chromatograms obtained from UPLC-HRMS 
analysis of rat urines from both treated (upper panel) and control rats (lower panel). 
  
As a first step of data analysis, we searched for expected metabolites directly related to the 
resveratrol metabolism in the treated group. We found resveratrol phase II metabolites, namely 
resveratrol-glucuronide (m/z 405.1180 and the fragment at m/z 229.0866), resveratrol-sulfate 
(m/z 309.1314 and the fragment at m/z 229.0866) and dihydroresveratrol glucuronide (m/z 
407.1344 and the fragment at m/z 231.1022), a metabolite derived from the action of gut 
microbiota and a phase II metabolic processing in the liver [29] (Table 3.2). No significant traces 
of un-metabolized resveratrol was detected in rat urines. 
 
Molecular identity Retention time (min) m/z value Adduct ion type 
Resveratrol-glucuronide 8.19 405.1180 [M+H]+ 
Resveratrol-sulfate 8.83 309.1314 [M+H]+ 
Dihydroresveratrol-glucuronide 8.38 407.1344 [M+H]+ 
Table 3.2. Identified resveratrol metabolites obtained by the analysis of UPLC-HRMS data of 
treated animals. The reported m/z values are from experimental data. 
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After the exclusion of the time x mass variables directly related to the metabolism of resveratrol, 
data modelling was performed by ptPLS2. The obtained model highlighted a clear effect of both 
time and treatment on the urine composition. The interaction term time x treatment was 
insignificant (Q27-fold CV = 0.003, p-value = 0.29). The model showed 2 parallel and 3 orthogonal 
components. Specifically, the model showed R2 = 0.89 and Q27-fold CV = 0.76 (p-value<0.001) 
for time while for the treatment resulted R2 = 0.89 and Q27-fold CV = 0.68 (p-value<0.001). 
Figure 3.2 reports the score scatter plot of the model, where it is possible to observe that the 
evolution of the urine composition during the experiment can be explained by considering two 
main effects, one related to the time passing and one related to the dietary intervention. 
 
 
Figure 3.2. Score scatter plot of the ptPLS2 model for UPLC-HRMS data. The plot shows 
modifications of the urine composition both due to treatment and to aging. Symbols of different  
shapes represent metabolic changes in urine along time. 
By Monte-Carlo stability selection, a reduced set of 34 measured variables was detected as 
relevant in the explanation of the effects of time and treatment in the metabolite content of the 
collected urines. Chemical characterization of the selected time x mass variables was tentatively 
performed by comparing the exact m/z value and fragmentation patterns with web-available 
databases (Human Metabolome Database, Metlin Database, Mass Bank Database) and 
interpreting their MSe spectra. 
A linear mixed-effects model considering first-order autoregressive structure with homogenous 
variances was applied to quantify the effects of time and treatment on the selected variables. As a 
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result, hypoxanthine, indole-3-carboxylic acid, 6-hydroxymelatonin, tetrahydrocortisol, 17-beta-
methylestra-1,3,5(10)-trien-3-ol, sebacic acid, 3-oxo-5beta-chol-6-en-24-oic acid, 11-
dehydrocorticosterone and 19-hydroxytestosterone predominantly contributed to the observed 
urinary metabolite differences due to P. cuspidatum extract supplementation as summarized in 
Table 3.3 while the most significant variables related to aging are reported in Table 3.4. 
Retention Time 
(min) 
HR m/z value Identification 
Treated vs. 
Control 
2.26 137.0460 Hypoxanthine ↓ 
6.92 162.0554 Indole-3-carboxylic acid ↓ 
8.58 249.1242 6-Hydroxymelatonin  ↑ 
11.17 271.2060 17-beta-methylestra-1,3,5(10)-trien-3-ol ↓ 
11.17 733.4891 Tetrahydrocortisol ([2M+H]+) ↓ 
11.34 225.1102 Sebacic acid ([M+Na]+) ↓ 
12.77 355.2634 
3-oxo-5beta-chol-6-en-24-oic acid ([M+H-
H2O]
+) 
↑ 
12.80 345.2064 11-Dehydrocorticosterone ↓ 
13.17 305.2116 19-Hydroxytestosterone ↓ 
Table 3.3. Significant variables (p-value<0.01) related to treatment for UPLC-HRMS data set. 
Variations of the metabolites are reported as increase (↑) or decrease (↓) in treated compared to 
control rats. 
Retention Time 
(min) 
HR m/z value Identification 
7.06 242.1757 (±)-Hexanoylcarnitine ([M+H-H2O]
+) 
5.80 260.1501 Unknown 
13.34 335.2376 Unknown 
13.39 410.2693 Unknown 
8.85 409.1832 Unknown 
4.45 318.1555 Isoleucyl-Triptophan ([M+H]+) 
13.50 448.3060 Unknown 
10.53 435.1285 Unknown 
13.17 359.1929 Unknown 
4.65 372.2385 Unknown 
3.08 413.1239 Unknown 
13.50 488.2987 Glycocholic acid ([M+Na]+) 
Table 3.4.  Significant variables related to rat aging, obtained from the ptPLS-DA VIP-based 
model for UPLC-HRMS data.  
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3.3.3  1H-NMR Measurements on 24-h Collected Urines 
In the 1D spectra (Figure 3.3) of treated rats, the resonances of resveratrol derivatives are 
evident. The NOESY spectrum confirms the presence of resveratrol-glucuronide and 
dihydroresveratrol glucuronide as shown in Figure 3.4. 
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Figure 3.3: Representative urine 1H-NMR spectra of a control rat and of a rat treated with P. 
cuspidatum. In the aromatic region (6.20 – 7.40 ppm), the presence of resveratrol derivatives in 
the treated (red) spectrum is evident. 
 
Figure 3.4. Portion of a NOESY spectrum in which NOE correlations between resveratrol (RES) 
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or dihydroreveratrol (DHR) aromatic protons with protons from glucuronic acid are shown. 
Pattern recognition was performed by PCA in order to highlight outliers or differences in the 
metabolite content of the urines collected at the beginning of the experiment. No outliers were 
detected or differences at day 0 related to the groups under investigation. Data modelling 
performed by ptPLS2 highlighted a clear effect of both time and treatment on the urine 
composition. The interaction term time x treatment was insignificant (Q27-fold CV = -0.02, p-value 
= 0.14). The model showed 2 parallel and 1 orthogonal components, R2 = 0.87 and Q27-fold CV = 
0.81 (p-value<0.001) for time and R2 = 0.60 and Q27-fold CV = 0.28 (p-value<0.001) for treatment. 
Figure 3.5 reports the score scatter plot of the model. It is possible to observe that two main 
effects, one related to the time passing and one related to the dietary intervention, to determine 
the evolution of the urine composition during the experiment.  
 
 
Figure 3.5. Score scatter plot of the ptPLS2 model for 1H-NMR data set. The plot shows 
modifications of the urine composition both due to treatment and to aging. Symbols of different 
shapes represent metabolic changing in urines along time. 
Monte-Carlo stability selection allowed us to select a reduced set of 21 bins. Table 3.5 reports 
the assignment of the selected bins related to the treatment effect while Table 3.6 that of the bins 
explaining the aging effect. 
Some metabolites were identified with the help of an online database (HMDB), literature [30] 
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and 2D-NMR spectroscopy. The metabolites affected by the treatment are 3-hydroxybutryate (3-
HB), glutamate, glycine, glucose, formate and two unassigned metabolites (Table 3.4). 
Dicarboxylic acid, lactate, acetate, succinate, 2-oxogluturate (2-OG), citrate, dimethyl glycine 
(DMG), creatinine, taurine and allantoin significantly change over the time period (Table 3.5). 
Interestingly, hippurate and betaine changed significantly both with time and treatment. Figure 
3.6 shows a typical 1HNMR spectrum in which metabolites responsible from time and treatment 
are highlighted. 
 
 
 
Figure 3.6. Typical 1D 1H-NMR spectrum of rat urine with enlargements of the aliphatic (0.6 – 
4.5 ppm, above panel) and aromatic (5.5 – 9.5 ppm, lower panel) regions. The resonances 
according to the time (red), treatment (black) and both (blue) effects are indicated. 
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Bin  Chemical shift (ppm) Metabolite 
Treated vs. 
Control 
[1.22- 1.28] 1.23 (d) 3-HB ↑ 
[2.46- 2.51] 2.48 (m) Glutamate ↓ 
[3.20- 3.24] 3.22 (s) Betaine ↓ 
[3.30- 3.34] 3.32 (s) U1 ↑ 
[3.52- 3.56] 3.56 (s) Glycine ↑ 
[4.00-4.04] 4.02 (m) U2 ↑ 
[5.22- 5.26] 5.25 (d) Glucose ↑ 
[8.25- 8.29] 8.26 (s) Formate ↑ 
[8.75- 8.79] 8.76 (t) Hippurate ↑ 
Table 3.5 Significant variables (p-value<0.05) related to treatment effect for the 1H-NMR data 
set. 
Bin Chemical shift (ppm) Metabolite Time effect 
[1.40-1.44] 1.42 (d) Lactate ↑ 
[2.07-2.11] 2.10 (s) Acetate ↑ 
[2.27-2.31] 2.28 (brs) Dicarboxylic acid ↓ 
[2.65-2.69] 2.68 (s) Succinate ↓ 
[2.69-2.73] 2.71 (t) 2-Oxogluturate ↓ 
[2.82-2.86] 2.86 (d) Citrate ↓ 
[2.94-2.97] 2.95 (s) Dimethyl glycine ↑ 
[3.11-3.14] 3.13 (s) Creatinine ↑ 
[3.20-3.24] 3.22 (s) Betaine ↑ 
[3.25-3.30] 3.28 (t)/ 3.29 (s) Taurine/TMAO ↑ 
[3.41-3.46] 3.44 (t) Taurine ↑ 
[8.75- 8.79] 8.76 (t) Hippurate ↓ 
Table 3.6.  Significant variables (p-value<0.01) related to rat aging for the 1H-NMR data set. 
3.3.4 Allantoin and 8-OHdG Quantification in Urine Samples 
Because of the reported antioxidant activity of resveratrol, we decided to measure the urinary 
levels of two well-known oxidative stress biomarkers by HPLC-MS/MS, namely allantoin and 8-
OHdG as shown in Figure 3.7. The total amounts of each biomarker in the collected urines were 
assessed monitoring the major fragments of allantoin and 8-OHdG at the beginning and at the 
end of the experiment (day 49) by MS/MS method ([M+H]+ at m/z 159/116 and [M+H]+ at m/z 
284/168 respectively). Data are summarised in Table 3.7. The content of 8-OHdG in the urines 
weakly decreases for the treated rats (t-test p-value = 0.05) while it does not change for the 
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control rats (t-test p-value = 0.47). At the beginning of the experiment, urinary 8-OHdG 
concentration was 10.83 ± 0.54 ng/mL for the treated rats and it weakly decreased to 8.64 ± 0.92 
ng/mL at the 49th day of treatment. Allantoin concentration significantly decreased for both 
control and treated rats (t-test p-value = 0.02 and test p-value<0.001, respectively). Specifically, 
for control rats the allantoin concentration decreased from 1.75 ± 0.08 µg/mL to 1.01 ± 0.18 
µg/mL while for treated rats from 1.54 ± 0.06 µg/mL to 0.41 ± 0.05 µg/mL. We can conclude 
that the reduction of the concentration of these two markers was more relevant for treated rats 
than control rats suggesting a reduction of oxidative stress in the treated group. 
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Figure 3.7. Urinary variations of 8-OHdG and allantoin from the beginning of the experiment to 
the end. Results obtained from rats supplemented with P. cuspidatum extract are compared to 
results obtained from the control group. Values are represented as means ± SEM. p-values 
calculated in unpaired t test. p< 0.05 (*), p < 0.001 (***). 
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8-OHdG Day 0 Day 49 t-test p-value 
Control 9.54 ± 0.49 ng/mL 10.35 ± 1.05 ng/mL 0.47 
Treated 10.83 ± 0.54 ng/mL 8.64 ± 0.92 ng/mL 0.05* 
Allantoin Day 0 Day 49 t-test p-value 
Control 1.75 ± 0.08 g/mL 1.01 ± 0.18 µg/mL 0.02* 
Treated 1.54 ± 0.06 µg/mL 0.41 ± 0.05 µg/mL <0.0001*** 
Table 3.7. Urinary variations of 8-OHdG and allantoin from the beginning of the experiment to 
the end. Results obtained from rats supplemented with P. cuspidatum extract (treated) are 
compared to results obtained from the control group (control). Values are represented as means ± 
SEM. p-values calculated in unpaired t test. p < 0.05 (*), p < 0.001 (***). 
 
3.4 Discussion 
P. cuspidatum extract (100 mg/kg) containing 20% of resveratrol was administered to rats to 
study the effect of this natural product in a healthy animal model through the observation of 
metabolic urinary changes. The underlying physiological changes responsible for these results 
are currently under examination. Below, a partial analysis is presented. 
Urines from treated animals showed decreased levels of hypoxantine and indole-3-carboxylic 
acid (ICA). Hypoxanthine is normally detected in urines and blood, but increased levels could be 
related to oxidative stress [31-32]. Also increased urinary levels of indole-3-carboxylic acid 
(ICA), a tryptophan metabolite normally detected in urines [33], can be related to oxidative stress 
and were reported in diet-induced hyperlipidemic rats [34]. 
Thus, our results suggest that P. cuspidatum extract supplementation in healthy rats reduces 
oxidative stress. This observation was confirmed by specific measurement of two urinary 
markers of oxidative stress. Allantoin is formed from the stepwise degradation of uric acid due to 
the reaction with oxidative species [35]. Allantoin is present also in urine of healthy subjects and 
its level is increased with increasing oxidative stress in the body [36]. 8-OHdG is a product of 
mitochondrial and nuclear DNA oxidative damage formed by the 8-hydroxylation of the guanine 
base by reactive oxygen species [37]. The oxidized nucleoside is enzymatically cleaved from the 
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DNA chains, is released in the bloodstream, and is eventually eliminated in the urines [37]. This 
biomarker is present in urines from healthy subjects, and variations of its urinary levels suggest 
alterations of the oxidative status. Thus, the observed reduction of both these metabolites in 
treated groups support an in vivo antioxidant effect of P. cuspidatum supplementation. 
The treated group showed increased levels of urinary 6-hydroxymelatonin, a hydroxylated 
hepatic metabolite of melatonin, mainly excreted in urine. Previous studies reported that 
melatonin and its metabolites exert both immunomodulatory and antioxidant activities [38-39]. 
Its meaning in the P. cuspidatum mode of action need to be deeply investigated. 
Different metabolites were identified as steroid derivatives. Among all, amounts of 
tetrahydrocortisol, 17-beta-methylestra-1,3,5(10)-trien-3-ol, 11-dehydrocorticosterone and 19-
hydroxytestosterone, a metabolite derived from androgen and estrogen metabolism [40], were 
detected in  lower amount in treated rat urines. A biliary acid derivative was also identified, (3-
oxo-5beta-chol-6-en-24-oic acid), and its urinary amount was increased in the treated group. 
Tetrahydrocortisol is a urinary metabolite of cortisol [41] and its urinary levels can be increased 
by ACTH administration [42]. This preliminary observation can suggest a role for P. cuspidatum 
extract as stimulant of corticosurrenal hormones thus being related to anti-stress or 
“adaptogenic” activity as Ginseng or similar herbal products [43]. The role of resveratrol on 
cortisol biosynthesis was previously investigated in vitro showing that the compound is able to 
stimulate cortisol biosynthesis by activating SIRT-dependent deacetylation of P450scc [44]. The 
change in sterol and corticosterol levels may be related to some of the health promoting effects 
of resveratrol, but these are the data first indicating a role of this natural compound on the levels 
of these physiological metabolites, and this aspect needs deeper investigations. 
Sebacic acid is a medium chain dicarboxylic acid normally detected in urines. It is involved in 
lipid and carbohydrates metabolism. MS data show that P. cuspidatum supplementation 
decreased its urinary amounts, suggesting a role on energy metabolism in rats. The 1H-NMR data 
show a significant decrease of a dicarboxylic acid (possibly sebacic or suberic acid) only with 
time. Dicarboxylic acids such as suberic acid are mainly metabolized in the liver by the ω-
oxidation pathway; thus, their increase in urine can indicate an influence of aging and of the 
treatment on liver function. Specifically, the decrease of the urinary levels of such compounds 
may indicate a decreased fatty acid ω-oxidation. Previously published studies reported that 
variations in urinary excretion of dicarboxylic acids and urinary dicarboxylic aciduria are related 
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to defective fatty acid metabolism [45]. Oddly, our previously published study on curcumin 
indicated lower levels of dicarboxylic acid in the control group [19]. These results are globally 
not completely consistent and require further analysis. 
Hippuric acid was found to be higher in P. cuspidatum treated rats as compared to the control rats 
and it also decreased with time. Hippuric acid is a normal component of urine and is typically 
increased with increased consumption of phenolic compounds (tea, wine, fruit juices) [46-47]. 
The increased urinary excretion of hippurate suggests alterations in gut microflora induced by P. 
cuspidatum because urinary hippuric acid excretion was not detected in volunteers without colon 
[53]. 
 
3.5 Conclusions 
Nutraceuticals and supplements containing herbal remedies are mainly used by healthy subjects 
as disease preventive or health maintaining purposes. Nevertheless, scientific investigations on 
the effects of such natural products on healthy subjects are largely missing. P. cuspidatum is a 
natural source of resveratrol, a stilbenoid claimed to be a powerful antioxidant used as food 
supplement or nutraceutical in hyperlipidaemia, inflammation, and age related diseases. In this 
study, using both 1H-NMR and UPLC-MS measurements, we performed a longitudinal study to 
assess the urinary metabolomic changes induced by 49 days supplementation of P. cuspidatum to 
healthy rats. This approach may offer a new view of the possible mode of action of herbal 
remedy supplementation containing resveratrol.  Our data showed that resveratrol is subject to 
extensive metabolism and urinary excretion that can be detected both with MS and 1H-NMR 
techniques. No oxidized resveratrol or oxidised resveratrol metabolites were detected suggesting 
a negligible role of its “direct” antioxidant activity. Resveratrol induced changes in the 
endogenous urinary profile, and the levels of urinary markers of oxidative stress confirmed the in 
vivo antioxidant effect of this supplement. We detected changes that could be ascribed to 
treatment or to aging. The many changes observed await a complete interpretation in terms of 
modification of biochemical pathways. 
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Chapter 4: An NMR based metabolomics approach to seek reliable markers 
to distinguish between Citrus and Clementine Italian honey with chemometric 
analysis. 
4.1 Aims of the work 
NMR-based metabolomics is a fast, convenient, and effective tool for origin discrimination and 
biomarker discovery in food analysis. Traditionally, the determination of the floral origin of 
honey is made from palynological analysis. The method is based on the identification of pollen 
by microscopic inspection. However, melissopalynological analysis needs expertise and also it is 
not very reliable for several botanical origins. The aim of this project was to develop an NMR-
based metabolomic approach that used multivariate statistical analysis to discriminate the 
botanical origin of different types of honey. Multivariate statistical analysis helped us to identify 
the most relevant signals to differentiate honey botanically. The obtained data sets were useful in 
the search of markers responsible for the discrimination of two types of citrus honey.  
4.2 Introduction 
Honey has a long history of human consumption; it is taken as medicine, eaten as food, or 
incorporated as an additive in a variety of foods and beverages. Honey is mainly composed of a 
complex mixture of carbohydrates and other minor substances, such as organic acids, amino 
acids, proteins, minerals, vitamins, and lipids. In almost all honey types, fructose predominates, 
glucose being the second main sugar. These two account for nearly 85–95% of the honey 
carbohydrates. Di- or oligo-saccharides constitute the remaining carbohydrates, except for traces 
of polysaccharides. Honey also contains volatile substances which are responsible for the 
characteristic flavor [1]. A number of tools and methods can be used to ensure that a given honey 
belongs to a botanical variety that complies with the label. The most often used method is pollen 
analysis (melissopalynology) [2]. By studying the pollen in a sample of honey, it is possible to 
gain evidence of the genus of the plants that the bees visited. Generally, melissopalynology is 
used to combat fraud and inaccurate labelling of honey. However, melissopalynology is not an 
easy technique because it requires very experienced analysts and it is very time consuming. 
According to some authors, melissopalynology is valid only for the determination of 
geographical origin of honey while it is less valid to determine its botanical origin [3]. Because 
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of the high price of certain honey types, adulteration with materials of low cost and nutritional 
value or mislabeling regarding the botanical origin sometimes occurs. Nonetheless, the 
discrimination between different types of honey is important for honeys that possess discrete 
aroma and taste and special nutritional properties which make them preferable for consumers.  
Honey made primarily from the nectar of one type of flower is called monofloral honey, whereas 
honey made from many types of flowers is called polyfloral honey. Theoretically, a monofloral 
honey can be produced from every plant that produces nectar. However, in practice, monofloral 
honeys are not so easy to produce. Thus, their price is, in most cases, higher than polyfloral ones, 
especially for certain types of monofloral honeys. Also, monofloral honey typically has a higher 
value in the marketplace due to its distinctive flavor. The need to find reliable marker 
compounds to discriminate between monofloral honeys is necessary [4]. Marker compounds can 
not only characterize a certain type of honey, but they can also show adulteration in honey [5]. 
Several analytical platforms such as gas chromatography/mass spectrometry (GC/MS) [6], 
nuclear magnetic resonance spectroscopy (NMR) [7], infrared spectroscopy (IR) [8] have been 
used for the chemical analyses of honeys and their classification. 
4.2.1 Citrus Honey 
Citrus honeys are considered to be among the best monofloral honeys. They are highly 
appreciated by consumers because of their distinctive and pleasant flavor and aroma and they 
usually sell at a premium [9]. They are obtained from cultivated Citrus species (botanical family 
of Rutaceae), mostly orange but also, to a lesser extent, lemon, tangerine, grapefruit, lime, 
clementine, etc. Citrus honey is produced in several Mediterranean countries [10].  In Italy, it is 
very important due to its high economical value; citrus honey is one of the most important and 
valuable honey production in Calabria and it is one of the few Italian honeys which is exported. 
This production, however, suffers the competition from similar products coming from other areas 
of the world, especially Spain, but also Mexico, Israel, the United States, and Brazil. Citrus 
honey is commonly commercialized without distinction between the different citrus species 
(Citrus sinensis L., Citrus deliciosa Ten., Citrus limon L., etc.) or at best as orange blossom 
honey. However, some honeys from botanical varieties of the citrus genus, such as Clementine, 
have excellent individual properties and could be commercialized independently and not just as 
citrus honey. Like other monofloral honeys, the botanical classification of Citrus reticulata must 
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be carried out by identification and quantification of the percentage of pollen by microscopic 
examination. The problem is that pollen analysis is considered of little value for the citrus genus 
as it is one of the several types of honey whose pollen is considered to be “under-represented” 
[11]. In other words, the amount of pollen present in citrus honey on occasions is lower than the 
quantity expected considering organoleptic characteristics such as flavor. This is because anther 
maturity does not always coincide with maximum secretion of nectar. Therefore, due to the 
difficulties in proving the botanical source of citrus honey using pollen analysis, the 
classification is based on the identification of specific chemical components present in different 
types of citrus honey, such as antioxidants or aromatic fractions [12]. Few reports indicate the 
presence of methyl anthranilate (MA) as a marker of citrus honeys in analyses of Spanish and 
Mediterranean citrus honeys [13]. However, this compound may also be present in honeys of 
other origins [14]. Other compounds, including hotrienol and the isomers of lilac aldehyde and 
-4-dimethyl-3-cyclohexen-1-acetaldehyde, have been proposed for differentiating citrus honeys 
[15]. Moreover, a report concludes that MA content cannot be used as a discriminating parameter 
for Citrus honey, and should be used only as a further descriptive element. Among the 
monofloral samples, the MA content was lower in those produced in Italy than in the countries, 
and mostly below the 2 mg/kg limit that some European laboratories require to accept Citrus 
honey [16]. It is therefore of great importance to improve the extraction techniques used so far, 
as well as to develop new ones to enable the analysis of honey non-volatiles to become a routine 
procedure. In this regard, the purpose of this study was also to establish an extraction method 
apart from the already reported ones [17, 18] to characterize and enhance the MA content 
measured in Italian citrus honey. We were not able to identify the MA in the chloroform 
extraction and therefore we directly extracted citrus honey in CDCl3 rather than first dissolve it in 
water. 
4.2.2 European Commission Legislation 
Honey regulation in the EU (Codex Alimentarius Commission 2001; European Commission 
2002) states that the botanical and geographical origins of the product must be printed on the 
label. The control of commercially sold honey therefore requires the determination of parameters 
that unambiguously establish the origin as part of the overall quality of honey. Honey fraud 
involves adding either industrial sugar syrups or mixing several floral origins, and selling the 
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product under a false name. The Commission of the EU is encouraging the development of 
harmonized analytical methods to permit the verification of compliance with the quality 
specifications for the different honeys. 
4.3 Methods and Materials 
4.3.1 Chemicals 
CDCl3 (99.96%-d, H2O 0.005% Euriso-Top, Gif sur Yvette, France), D2O (99.9%-d,) were 
purchased from Sigma Aldrich (Milan, Italy). 
4.3.2 Honey Samples 
Eighty two samples of citrus honey were obtained from an exhibition called “GD” (golden drop) 
an annual exhibition in Italy where honey producers from all over Italy exhibit honeys from 
different botanical and geographical origin. We particularly acknowledge Lucia Piana for 
providing these samples after verification of their botanical origins in most of the cases by 
melissopalynlogic analysis. Details of the honey samples is given in Table 4.1. 
S. No. Honey type Botanical origin No. Of samples 
1 Citrus C. sinensis 31 
2 Clementine C. reticulate 51 
Table 4.1: Details of citrus honey samples used in this study. 
4.3.3 Sample Preparation: 
4.3.3.1 Direct CDCl3 Extraction of Honey 
Six g of honey are dissolved in a Teflon tube with 1.5 mL of D2O and 1.5 mL of CDCl3 and 
mechanically stirred for 15 min. The resultant solution is centrifuged for 15 min at 10,000 rpm 
and 4 °C. After centrifugation, the lower CDCl3 phase (600 µL) is collected and transferred into 
an NMR tube for analysis.  
4.3.3.2 Direct D2O Extraction of Honey 
One hundred ± 0.03 mg of citrus honey are dissolved in 600 µL of D2O and mechanically stirred 
until complete dissolution to obtain a homogenous mixture; the pH of the resulting solution is 
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then adjusted in the range of 2-3 by adding 8 µL of 1 M HCl. Finally, 600 µL of honey solution 
is transferred into an NMR tube for analysis. 
4.3.4 1H-NMR Spectroscopy 
For CDCl3 extraction spectra were recorded on a Bruker Avance 600DMX instrument, operating 
at 599.99 MHz for 1H and equipped with a 5 mm TXI xyz gradient inverse probe. The 1D 
spectra were acquired using a modified double pulsed field gradient spin echoes (DPFGSE) 
sequence [17]. The typical acquisition parameters of this experiment were as follows: 
temperature, 298 K; recycle time, 2 s; spectral window, 6000 Hz; number of scans, 256; data 
points, 32K; receiver gain, 8K. The parameters for the 1D spectra obtained with the standard 
single-pulse sequence were as follows: temperature, 298 K; recycle time, 2 s; spectral window, 
6000 Hz; number of scans, 1024; data points, 32K; receiver gain, 256. In the case of D2O 
extraction, all the parameter were same except that 8K data points were acquired and the number 
of scans was used 512. 
Data for CDCl3 extraction samples were processed using the ACD software (ACD/Specmanager 
7.00 software, Advanced Chemistry Development Inc., 90 Adelaide Street West, Toronto, 
Ontario, Canada M5H 3V9). Fourier transformation was performed after zero-filling the FID 
data to 128K points and after apodization using a decreasing exponential with line broadening of 
0.5 Hz. The spectra were phased and baseline-corrected using the ACD manual routine, and the 
1H NMR chemical shifts were referenced to the residual CHCl3 signal at 7.27 ppm. Each 
1H 
spectrum was segmented into identical intervals (“buckets”) of 0.04 ppm, and the signal intensity 
in each interval was integrated. The spectra were normalized to the total sum of integral covering 
the δ interval 13-2.16 and excluding the δ region 7.26-7.28, which contains the residual solvent 
peak. The resulting normalized integrals composed the data matrix that was submitted to 
multivariate analysis. 
For D2O extraction, spectra were processed using the ACD software (ACD/Specmanager 7.00 
software, Advanced Chemistry Development Inc., 90 Adelaide Street West, Toronto, Ontario, 
Canada M5H 3V9). Fourier transformation was performed using interactive FT after zero-filling 
the FID data from 8K to 32K points and after apodization using a Sq. cosine function. The 
spectra were phased and baseline-corrected using the ACD manual routine; we used the signal of 
Tyrosine at 6.80 ppm as a reference. Each 1H spectrum was segmented by using intelligent 
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bucketing and the signal intensity in each interval was integrated. The spectra were normalized 
to the total sum of integral covering the δ interval 6-9 ppm and excluding the δ region 3-6 and 9-
13 ppm which contains the sugars and empty region (without any important peak), respectively. 
The resulting normalized integrals composed the data matrix that was submitted to multivariate 
analysis. 
4.3.5 Statistical Analysis: 
Principal component analysis (PCA) and (Ortho partial least square discriminate analysis) 
OPLSDA using “mean centering” as data pretreatment was performed using the software 
SIMCA-P13 (Umetrics, Umea, Sweden). Data were visualized by plotting either the PC scores, 
where each point in the score plot represents an individual sample, or the loading plot, which 
permits us to identify the spectral regions with the greatest influence on the separation and 
clustering of the samples and, therefore, to deduce which compounds are responsible for such 
clustering (markers). 
4.4 Results and Discussion 
4.4.1 D2O extraction of honey: 
Figure 4.1A shows a typical 1H-NMR spectrum of citrus honey dissolved in deuterated water, 
showing the dominant resonances of fructose and glucose, honey’s main components. These 
sugars signals are not relevant for our study. Therefore, we exclude the aliphatic and sugar 
region from our consideration and emphasize the aromatic region (6-9 ppm). Figure 4.1B shows 
the expansion of the aromatic region of only one citrus honey magnified 6 times compared to the 
original spectrum. Figure 4.2 shows the aromatic region of all the 82 spectra of clementine and 
citrus honey. Several signals in the NMR spectra differ in intensity. To specify differences and 
similarities, multivariate data analysis was used. 
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Figure 4.1: (A) Complete 1H NMR spectrum of a citrus honey sample dissolved in D2O. 
Expansion of the aromatic region (B). 
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Figure 4.2: Tile plot of all spectra of citrus honeys: region between 6 and 9 ppm of clementine 
(black) and citrus (red) honeys. 
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As a first step, an unsupervised approach by means of PCA was applied to overview the data, to 
find out outlier and pattern of data set (Figure 4.3). The plots of the first two PCs of all the PCAs 
showed low sensitivity and selectivity and also show poor separation of the two groups.  
 
Figure 4.3: PCA score plot derived from the aromatic region of 1H NMR spectra of honey 
dissolved in deuterated water. The plot shows the poor discrimination between clementine (red) 
and citrus honeys (green).  
This result prompted us to perform a supervised technique, i.e., OPLS-DA. The score plot of the 
OPLS-DA model obtained, reported in Figure 4.4A, shows good separation of honey samples 
into clementine (red) and citrus (blue) honey, with R2 X = 79.5%, R2 Y=39.2% and Q2 = 54.5%. 
On the basis of the Hotelling’s T2 test at the confidence level of 95%, we identified five strong 
outliers, which were excluded from the dataset. In Figure 4.4B, the S-plot allowed us to specify 
the variables (chemical shifts), which are responsible for the observed clustering and hence led 
us to the identification of markers responsible for the two different origins. The marker 
compounds were identified, using literature [19] and online free NMR metabolomics databases 
such as HMDB (http://www.hmdb.ca/) and SDBS (http://sdbs.db.aist.go.jp/sdbs/cgi-
bin/cre_index.cgi). According to the S-plot, phenylacetic acid and tyrosine are strong 
discriminants for citrus honey while formic acid is less discriminating for clementine honey, 
although it is consistently more intense in clementine than in citrus honey. Chemical structures 
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and chemical shifts are given in Table 4.2. Since we used Pareto scaling, the discrimination is 
based on consistently different intensity of the same signal in the two types of honey. Figure 4.5, 
shows two NMR spectra of orange and clementine honeys in comparison. To the best of our 
knowledge, it is the first time that Tyrosine, Phenylacetic acid and Formic acid were reported in 
citrus honey. Tyrosine and Formic acid have been reported as markers for Polish buckwheat 
honey and Polish heather honey shows phenylacetic acid as a marker [19]. 
 
Figure 4.4A: OPLS-DA score plot derived from the aromatic region of 1H NMR spectra of 
honey dissolved in deuterated water. The plot shows the clear discrimination between clementine 
(red) and citrus honeys (blue).  
 
Figure 4.4B: S-Plot showing the important resonances for the distinction of the two honey types. 
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Figure 4.5: Aromatic region (6-9 ppm) of the 1H-NMR spectra of clementine (red) and citrus 
(blue) honeys in D2O. 
Name Structure Position 1H Chemical shift 
Phenylacetic 
acid 
 
4 
3,5 
2,6 
7 
7.37 ppm 
7.27 ppm 
7.30 ppm 
3.37 ppm 
(overlapped by 
sugar region) 
Formic acid 
 
2a 8.12 ppm 
Tyrosine 
 
2,6 
3,5 
8,9 
6.80 ppm 
7.10 ppm 
Overlapped with 
carbohydrate region 
 
Table 4.2: Assignment of marker compounds with their structure. 
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Model validation was performed following good practice, N-fold full cross-validation with value 
of N (N = 10) and permutation test on the responses (100 random permutations), in order to 
avoid over-fitting and prove the robustness of the obtained models. Figure 4.6 represents the 
obtained model by permutation tests based on prediction accuracy. The p-value based on 
permutation is p < 0.01 (0/100). The number of components of the PLSDA models was 
estimated on the basis of the first maximum of Q2 calculated by 10-fold full cross-validation 
under the constraint to pass the permutation test on the responses. 
  
Figure 4.6: PLS-DA model validation by permutation tests based on prediction accuracy. The p 
value based on permutation is p < 0.01 (0/100). 
4.4.2 CDCl3 Extraction of Honey 
Methyl anthranilate (MA) is widely accepted as a marker compound of citrus honey [17, 20-21]. 
In work conducted previously in our lab, we did not find MA using the chloroform extraction 
method previously developed [17], so we decided to perform a direct extraction of honey in 
deuterated chloroform to analyze the chloroform layer directly without evaporation. However, 
we were not able to see MA in these samples either. Sesta et al. [20] concluded that the MA 
content cannot be used as a discriminating parameter for Citrus honey, and should be used only 
as a further descriptive element. Among the monofloral samples, the MA content was lower in 
those produced in Italy than in other countries, and mostly below the 2 mg/kg limit that some 
European laboratories require to accept Citrus honey [20]. The NMR spectra acquired with direct 
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CDCl3 extraction showed better resolution and signal to noise ratio in comparison with the 
spectra obtained using previously established methods [17, 18]. Figure 4.7 shows all the NMR 
spectra of citrus honey acquired by direct CDCl3 extraction.  
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Figure 4.7: Tile plot of all spectra of citrus honeys extracted directly in CDCl3: Full length 
spectra between 2.6 and 13 ppm of clementine (red) and citrus (black) honey honeys. 
Figure 4.8 represents the loading plot of the OPLS-DA model of all the honey samples using 
UV scaling. The first two PC’s on the basis of Hotelling’s T2 95% revealed clear separation of 
two types of honey, even better than the one obtained in D2O. The model diagnostics were 
summarized by the fit goodness, R2 (84.9%) and the prediction goodness parameter Q2 (77.7%). 
 
Figure 4.8: OPLS-DA loading plot derived from the 1H NMR spectra of CDCl3 extracts of 
honeys. The plot shows the clear discrimination between clementine (red) and citrus honeys 
(blue).  
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Figure 4.9: S-plot showing the important resonances for the distinction of the two honey types. 
 
 
Figure 4.10: Comparison of citrus (blue) and clementine (red) 1H NMR spectra.  
a) Whole NMR spectra. b) Expansion of the spectral region 5.8-3.0 ppm. 
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These resonance can be recognized as caffeine and 8-dihydroxylinalool from already reported 
work [17]; two resonances, assigned to an unknown compound which are present in the 
clementine samples. A single representative spectrum from each type of citrus honey is shown in 
Figure 4.10. All the marker resonances for citrus honey extracted in deuterated chloroform are 
presented in Table 4.3. 
Name Structure Position 1H Chemical Shift 
8-hydroxylinalool 
 
 
1 
3 
4 
5 
7 
8a 
8b 
2` 
6` 
4.00 
5.43 
2.08 
1.61 
5.93 
5.09 
5.24 
1.68 
1.30 
Caffeine 
 
8 
10 
11 
12 
7.55 
3.42 
3.61 
4.01 
Unknown - - 4.88 & 3.76 
 
Table 4.3: Assignment of the marker compounds extracted in CDCl3. 
4.5 Conclusions 
In total, we analyzed 82 samples for each extraction method adopted for citrus honey. Herein, we 
only discussed the results obtained from direct dissolution in D2O and from direct CDCl3 
extraction. The results from chloroform (CHCl3) extraction have already been reported from our 
lab [17-18] and were not described here. Among possible multivariate statistical tools, the 
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hierarchical OPLS-DA demonstrated high efficiency in NMR data analysis in terms of 
classification capability, as already demonstrated [17]. Using our new method of direct CDCl3 
extraction, we achieved better signal to noise ratio and also discovered a new marker 
(Unknown). According to our knowledge, this is the first attempt to discriminate clementine and 
citrus honeys. Our D2O extraction strategy revealed phenylacetic acid and tyrosine as marker 
compounds in citrus honey whereas higher amounts of formic acid characterized clementine 
honey. We did not find MA into either honey types studied; however, high amounts of 
phenylacetic acid and tyrosine distinguish citrus honey from clementine honey. NMR-based 
metabolomics gave a descriptive view of two types of honey belonging to the same botanical 
species.  
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Chapter 5. Determination of auuthenticity and entomological origin of 
Ecuadorian honey by NMR 
5.1 Aim of the work 
Increasing production of stingless-bee honey and the prospect of broader marker for natural and 
organic products indicate the need to establish parameters to determine the entomological origin 
and authenticity of honey. In this context, we received from Dr. Patricia Vit 83 Ecuadorian 
commercial honeys from four different entomological origins, i.e., Apis mellifera, Geotrigona, 
Melipona and Scaptotrigona, plus eight false or adulterated honey samples. A simple extraction 
in chloroform followed by acquisition of a 1H-NMR spectrum of each honey sample yields a 
database amenable to chemometric analysis. In a first approach, NMR results were used to 
distinguish between the genuine Apis mellifera honey and false honey. In a second step, the 
NMR spectra were analyzed with a chemometric approach to distinguish the entomological 
origin of honey produced by Apis mellifera and pot-honey produced by the genera Geotrigona, 
Melipona, and Scaptotrigona. The important compounds for the authentication of the honey 
determined with the chemometric approach were identified with the aid of online databases and 
2D NMR spectroscopy. 
5.2 Introduction 
Honey has a great importance in both ancient and modern civilizations with many functional 
applications. Apart from being simply used as a sweetener, honey is widely known both as food 
with significant nutritional properties and as a natural product with valuable therapeutic 
applications, topically or orally administered [1]. Stingless bees, sometimes called stingless 
honey bees or simply meliponines, are a large group of bees (about 500 species), comprising the 
tribe Meliponini [2]. However, stingless bee honeys are better known and mainly used in South 
America, Africa and Australia, while honeys derived from A. mellifera are mainly produced and 
distributed in Europe and Asia [1]. Beekeeping with honey bees belonging to the genus Apis is 
more widespread than meliponiculture – beekeeping with stingless bees (e.g., Melipona spp.) – 
which is a well-known tradition in tropical countries. Both groups of bees belong to the family 
Apidae, order Hymenoptera. They are differentiated at the subfamily level, Apinae for honey 
bees and Meliponinae for stingless bees. The main structural differences between honey bees and 
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stingless bees is nest construction: stingless bees construct horizontal combs made of cerumen (a 
mixture of propolis and beeswax) for their nests, and honey pots instead of honeycombs for 
storing honey [3-4]. Stingless bee honey is completely different from that produced by the bees 
of the genus Apis and it reaches higher prices in the market compared with traditional honey. 
Nevertheless, standards have not been created for pot-honey [5]. The Codex Alimentarius 
Commission international honey standards for honey are designed only for Apis mellifera [6]. To 
authenticate the entomological origin, chemical makers such as fructose, glucose and maltose 
have been used in a multivariate analysis [7], physical-chemical parameters [8], sensory Free 
Choice Profile (FCP) [9], NMR and chemometrics [10], flavonoid C-glycosides [11] and O-
glycosyl flavones [12], and more recently electrophoretic patterns because different species of 
stingless bees produce honey with distinctive protein bands [2].  
Pot-honey price can reach up to 1,100% that of Apis mellifera honey. This great difference is a 
motivation to declare a false entomological origin, causing an Economically Motivated 
Adulteration (EMA), to be added to the four types of EMAs causing vulnerabilities in the US 
honey market: 1. Dilution with syrups, 2. Feeding sugar to bees during nectar offer, 3. Masking 
countries of origin, and 4. Antibiotic residues after excessive veterinary doses [13]. Therefore, it 
is of great importance to develop a method to certify the entomological origin of honey and to 
create a rapid method to avoid adulteration of the pot honey. 
5.3 Method and Materials 
5.3.1 Honey Samples 
Eighty three commercial honeys from Ecuador were purchased in markets or received from local 
stingless bee keepers. The entomological origin were declared by the beekeeper. 
5.3.2 Sample Preparation: 
Precisely weighed amounts (6.00 ± 0.01 g) of honey were placed in Teflon tubes and dissolved 
in 15 mL of deionized water; the pH of each sample was maintained between 2 and 3 using small 
volumes of HCl. Fifteen mL of CHCl3 were added and the mixture was mechanically stirred for 
15 min and then centrifuged at 10,000 rpm for 15 min at 4 °C. The lower chloroform phase was 
collected in a glass vial and the solvent was evaporated under a gentle stream of nitrogen. The 
solid residue was reconstituted in 600 μL of CDCl3 and placed in an NMR tube for the analysis. 
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5.3.3 1H-NMR Spectroscopy 
Spectra were recorded on a Bruker Avance 600DMX instrument, operating at 599.99 MHz for 
1H and equipped with a 5 mm TXI xyz gradient inverse probe. The 1D spectra were acquired 
using a modified double pulsed field gradient spin echoes (DPFGSE) sequence. The typical 
acquisition parameters were as follows: temperature, 298 K; recycle time, 2 s; spectral window, 
6000 Hz; number of scans, 256; data points, 32K; receiver gain, 8K. 
5.3.4 1H-NMR Data Reduction and Processing 
ACD software (ACD/Specmanager 7.00 software, Advanced Chemistry Development Inc., 90 
Adelaide Street West, Toronto, Ontario, Canada M5H 3V9) was used for data reduction and 
processing. Fourier transformation was performed after zero-filling the FID data to 128K points 
and after apodization using a decreasing exponential with line broadening of 0.5 Hz. The spectra 
were phased and baseline-corrected using the ACD manual routine, and the 1H-NMR chemical 
shifts were referenced to the residual CHCl3 signal at 7.27 ppm. Each 
1H spectrum was 
segmented into intelligent bucketing, and the signal intensity in each interval was integrated. The 
spectra were normalized to the total sum of integrals covering the δ interval 9.45-2.16 and 
excluding the δ region 7.26-7.28, which contains the residual solvent peak. The resulting 
normalized integrals composed the data matrix that was submitted to multivariate analysis. 
5.3.5 Statistical Analysis 
Principal component analysis (PCA) and partial least square-discriminate analysis (PLS-DA) 
were conducted using the software SIMCA-P10 (Umetrics, Umea, Sweden). Data were mean 
centered and Pareto scaled. Data are visualized by plotting either the PC scores, where each point 
in the scores plot represents an individual sample, or the loadings plot, which permits us to 
identify the spectral regions with the greatest influence on the separation and clustering of the 
samples. 
5.4 Results and Discussion 
5.4.1 Authentication of Apis mellifera Honey Hamples: 
For the authentication of genuine honey, the study was carried out on 24 genuine Apis mellifera 
honey and 8 false honey samples. Figure 5.1 (A-B) shows the spectra of a false honey in 
comparison with genuine Apis mellifera honey. There is appreciable difference between the two 
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spectra. The genuine Apis mellifera honey complex spectrum derives from the biodiversity and 
complexity of plants and bees. Compounds distinguishing genuine Apis mellifera and false 
honey (Fig. 5.1) were identified with the help of our previously published report [14] and 
standard 2D NMR experiments. These compounds are listed in Table 5.1 
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Figure 5.1: (A) Complete 1H-NMR spectrum of a false honey sample in chloroform (red) and of 
an authentic Apis Mellifera sample (black). (B) Expansion of the aromatic region (4.5-9.2 ppm). 
Figure 5.2 A shows 1H-NMR spectra of 8 false (AMF) honeys in CDCl3, whereas Figure 5.2 B 
shows the main compounds that characterize them:  5-Hydroxymethyl furfural (5-HMF), 2-
Hydroxyacetyl-furan (2-HAF), Benzoic acid, and Sorbic acid. 5-HMF is also present in genuine 
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honey, but its amount is much higher in false honey. Benzoic and Sorbic acid were also present 
in 2 samples as preservatives.  
The Presence of 5-HMF in honey is unavoidable since low amounts of this compound naturally 
occur in fresh sugar containing food, such as honey and milk [15]. The content of 5-HMF 
depends on the temperature of the beehives, and it can increase at higher temperatures, becoming 
dangerous also for the health of the honey bee [16]. Moreover, its amount also depends on 
storage time and pH; therefore, it is normal practice to use the 5-HMF content as an indicator of 
adulteration and quality [15]. Both the Codex Alimentarius Commission (Alinorm 01/25, 2000) 
and the European Union (Directive 110/2001) established that its concentration usually should 
not exceed 40 mg/kg (80 mg/kg for tropical honeys) [17]. The presence of 2-HAF along with 5-
HMF is an indication of adulteration since both compounds are products of caramelization 
reactions. 
Preservatives are added into food deliberately with the purpose to save nutritional value and to 
increase the shelf life. Benzoic and Sorbic acid are two commonly used preservatives in the food 
industry and possesses the anti-microbial property to inhibit yeast and mold growth as well as to 
prevent the attack of bacteria [18]. Although widespread use of these preservative is common, 
still they have an adverse effect on human and animal health, such as metabolic acidosis, 
convulsions and hypernoea at high doses [19]. All the Apis mellifera genuine samples were 
characterize by the presence of an insoluble ether compound; Diacylglyceryl ether. Figure 5.3 
shows the structure of the marker of Apis mellifera genuine honey. All the resonances were 
assigned and identified with the help of previous work published by our group [14]. In that work, 
a metabolomic approach was used to discriminate honey belonging to different botanical origins 
but produced by Apis mellifera. Interestingly, this type of molecule has been found only in the 
muscles and liver of a giant squid and certain species of sharks. Diacylglyceryl ethers are 
fundamental molecules for these species as a short-term energy resource, and they may also be 
important in imparting buoyancy regulation [14]. 
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Figure 5.2: (A) Complete 1H NMR spectrum of 8 false honey samples in chloroform. (B) 
Expansion of the aromatic region (4.5-9.2 ppm). 
Honey samples Compound Chemical shifts (δ) 
False Honey 5-Hydroxymethyl furfural 4.76 (s); 6.56 (d); 7.25 (d); 
9.64 (s) 
2-Hydroxyacetyl-furan 4.77 (s); 6.63 (dd); 7.34 (d); 
7.66 (d);  
Sorbic acid 1.90 (d); 5.81 (d); 6.24 (m); 
7.36 (d) 
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Benzoic acid 7.52 (t); 7.65 (t); 8.15 (d) 
Genuine Apis Mellifera honey Diacylglycerylether 0.91 (t); 1.3 (m); 1.56 (m); 
1.64 (m); 2.04 (br);   3.45 
(m); 3.56 (dd); 4.18 (dd); 
4.35 (dd); 5.21 (m); 5.36 (m) 
Table 5.1: 1H-NMR data of identified compounds in false and genuine honey in CDCl3. 
 
 
 
 
 
Figure 5.3: Diacylglyceryl ether, a marker of Apis mellifera genuine honey.  
5.4.2 Authentication of Honey with Chemometric Analysis. 
Hierarchical Cluster Analysis (Figure 5.4) was applied to classify the samples based on spectral 
differences. In data mining and statistics, hierarchical clustering is a method which seeks to build 
a hierarchy of clusters. In general, the merges and splits are determined in a greedy manner. The 
results of hierarchical clustering are usually presented in a dendrogram or a heatmap. For the 
determination of spectral differentiation among studied groups, cluster analysis was performed 
via MetaboAnalyst (http://mirror.metaboanalyst.ca/). Total sum normalization was used for each 
spectrum in the range of 2.16- 9.50 ppm. Spectral distances were calculated between pairs of 
spectra as Pearson’s correlation coefficients and Euclidean distance was used to calculate the 
sample similarities and to indicate the complete linkage clustering by Ward’s algorithm.  
Use of chemometrics together with classical methods for the classification of different honey 
samples has been proposed in previous researches. PCA-like techniques can be preferred 
primarily for the determination of general relationship among data [20]. However, to group 
similar data gathered from different samples, cluster analysis must be performed [21]. Similar 
samples incline to be classified in the same cluster and the level of difference between the 
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clusters is indicated with heterogeneity values. Ward’s algorithm was previously reported to give 
one of the best predictions, among the different methods used in cluster analysis [20, 22]. 
 
Figure 5.4: Clustering dendrogram showing differences between Apis mellifera in red and false 
honey in green (distance measure using Euclidean, and clustering algorithm using Ward). 
The dendrogram shows clearly two clusters which represent the inter-sample similarity of 
genuine honey and dissimilarity with false honey. Hierarchical Cluster Analysis also provides 
the heatmap shown in Figure 5.5 where the top 10 important variables that discriminate false vs. 
genuine honey are indicated. A heat map is a graphical representation of data where the 
individual values contained in a matrix are represented as colors. 
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Figure 5.5: Clustering result shown as heatmap (distance measure using Euclidean, and 
clustering algorithm using Ward). 
The right hand side of the heatmap show the scale of the intensity of a particular variable in a 
particular sample. These features were selected on the basis of the VIP score plot (top 10). These 
variables represent the resonances of the Diacylglyceryl ether (from bees wax), a marker for the 
genuine when compared to the false honey. The heatmap shows absence (green color) of this 
compound in fake honey as also evident from the NMR spectrum of false honey (Figure 5.1). 
Table 2 summarizes the classification rate of the two honey types used for the authentication of 
genuine and false honey: the model classifies the honey samples with 100% accuracy. 
Classes Apis mellifera (AM)  False honey (F) Class. Error 
Apis mellifera (AM) 24 0 0.00 
False honey (F) 0 8 0.00 
Table 5.2: Classification of hierarchical clustering analysis model. 
5.4.3 Chemometric Approach for Entomological Origin Discrimination 
For the analysis of entomological origin of honey, we used 83 commercial honey samples 
belonging to four different entomological origin, namely Apis mellifera (25), Geotrigona (16), 
Mellipona (18), and Scaptotrigona (24). By using principal component analysis (PCA) and 
supervised techniques (projection to latent structures by partial least squares-discriminant 
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analysis, PLS-DA), a classification model according to entomological origin was obtained, with 
high predictability power. 
In the first step, we applied the PCA analysis to the four different types of honey samples; the 
scores plot is shown in Figure 5.6. Three outliers were detected using PCA analysis, which were 
eliminated from further analysis. 
 
Figure 5.6: PCA scores plot of all samples: Apis mellifera (red), Scaptotrigona (black), 
Melipona (blue) and Geotrigona (green).  
The PCA scores plot shows good separation between Geotrigona and Melipona groups, but there 
is not much difference between Scaptotrigona and Apis mellifera. Next, PLSDA was applied to 
visualize the subtle differences between the four groups; the scores plot is shown in Figure 5.7. 
A clear differentiation of samples according to the entomological origin was achieved. The 
model diagnostics were summarized for three components by the fit goodness, R2X (0.664), R2Y 
(0.929) and the prediction goodness parameter, Q2 (0.854). These values are considered good for 
a valid model. 
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Figure 5.7: PLSDA score plot of all samples: Apis mellifera (black), Scaptotrigona (green), 
Melipona (blue) and Geotrigona (G). 
The next step is to determine which resonances differentiate the four groups; therefore, we used a 
one-vs-all strategy through a PLSDA model where each class of honey was compared with the 
other honeys considered together as one class. Figure 5.8 (a-d) shows the scores plot of each 
entomological origin honey versus all as one class with their corresponding loadings plot to 
visualize the resonances important to differentiate between them.  
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Figure 5.8: PLSDA scores plot of 4 honey types (left) and corresponding loadings plot (right). 
(a) Apis mellifera vs all; (b) Melipona vs all; (c) Scaptotrigona vs all; (d) Geotrigona vs all. 
 
Figure 5.9: Clustering result showing differences between four observations: Apis mellifera, 
Scaptotrigona, Geotrigona and Melipona as a dendrogram (distance measured using Euclidean, 
and clustering algorithm using Ward). 
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The discrimination among the four different honey types was supported with cluster analysis 
(dendogram) after PCA and PLSDA analysis. The dendrogram in Figure 5.9 shows two main 
clusters (top to bottom). Three entomological classes of honey, namely Apis mellifera, 
Scaptotrigona and Geotrigona are merged into one big cluster whereas all Melipona honey 
samples are merged into one cluster. The two sub-cluster are merged into one big cluster through 
two nodes (bottom to top). These two sub-clusters are divided into 4 individual clusters as four 
unique observations represent each entomological origin. Two samples of Melipona honey, 
coded as HP73 and HP37 and indicated with arrows, are clustered along with Geotrigona and 
Scaptotrigona, respectively. Three samples of Apis mellifera, coded as HP64, HP57 and HP59 
are also merged with Scaptotrigona and Geotrigona, respectively. Out of these five samples, the 
ones coded as HP64, HP37 and HP57 were declared as adulterated samples using a classical 
approach physical-chemical and melissopalynological analysis (performed by Dr. Patricia Vit, 
sample provider). The other two honey samples coded as HP73 and HP59 are misclassified. 
 
5.5 Conclusions 
As a continuation of our work focused on the origin discrimination of Italian honey with a 
chemometric approach by NMR spectrometry, we received 91 samples from Ecuador, 83 
genuine honey and 8 false honey. In Ecuadorian markets, is it possible to find false honeys, 
composed entirely of inexpensive syrups or with a very little amount of genuine honey. 
Therefore, a method is needed which can be used as an alternative to classical ones to 
authenticate the honey and also to be used for entomological origin determination.  
A chemometric analysis of 1H-NMR data can discriminate between genuine and false honey. We 
found 5-Hydroxymethyl furfural, 2-Hydroxyacetyl-furan as main indicators of false honey. 
Moreover, Sorbic acid and Benzoic acid were not present in all false honey, but could be used as 
descriptors of false honey. We found a diacylglyceryl ether as the marker of genuine honey. The 
present study also demonstrates that a metabolomic approach based on 1H-NMR and associated 
with PLS-DA and cluster analysis is a very suitable tool to distinguish the entomological origin 
of honeys. The PLS-DA analysis further identified resonances belonging to different compounds 
responsible for the discrimination of entomological origin. The proposed method of chloroform 
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extraction requires very little sample preparation, is fast, reproducible, allows one to obtain a 
fingerprint of different classes of compounds at the same time, and is more objective than 
melissopalynological analysis. To the best of our knowledge, there is no report published on the 
use of NMR-based metabolomics to discriminate the entomological origin. We are aware of one 
recently published method based on electrophoresis to discriminate the stingless bee species 
from Mexico [2]. The initial findings in this work would be very helpful in the future to identify 
the unknown resonances to establish the entomological origin of Ecuador honey. 
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Chapter 6. General Conclusions 
The research that I have conducted at University of Padova over the course of three years was 
divided into two main topics under the common theme of “NMR-based metabolomics” in food 
chemistry: 1) The in vivo effects of nutraceutical products containing antioxidants on rat urine 
were evaluated using both NMR and MS; 2) An NMR-based metabolomic approach was applied 
to the discrimination of honey of different origins.  
The role of NMR-based metabolomics in food sciences has been expanding in the last decade 
after it was successfully applied to diseases, toxicology and in the medicinal area. The 
information available in the field of food chemistry is still scarce, therefore its potential and 
capability need to be explored. Recently, NMR-based metabolomics started to gain appreciable 
popularity in food stuff where it can be applied to food authentication. There is no argument for 
the low sensitivity of NMR as compared to MS; still, NMR is a method of choice for 
metabolomic studies because of its reproducibility and quantitative and non-destructive nature. 
Beside food authentication studies, i.e., origin discrimination of food matrices, NMR-based 
metabolomics recently also established itself in the assessment of phytochemical products and 
their metabolism in human and animal urine. Urine is a very convenient biological fluid to study 
because of the ease and non-invasive nature of multiple collections. Also, it is a biological waste 
which possesses important information of the living organism under study. The combination of 
NMR spectroscopy with data reduction techniques such as chemometrics to convert large 
datasets into valuable information have become a powerful tool in metabolomic studies, as we 
also prove in this thesis.  
In the first two chapters, we used both 1H-NMR and HPLC–MS techniques to study the 
modification of urinary composition in rats treated with C. longa L. and P. cuspidatum extracts 
and tried to correlate these changes with in vivo antioxidant activity. Multivariate analysis on 1H 
NMR and HPLC–MS data produced similar but not identical representations of the collected 
samples. Both approaches were able to detect variations in the urinary metabolome, leading to 
the observation of different components, showing the complementarity of these two analytical 
techniques for metabolomic purposes.  
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The evaluation of the effects of Curcuma extract (Chapter 2) on urinary composition in healthy 
rats by a metabolomic approach led us to observe evidence for an in vivo antioxidant effect 
caused by a significant reduction in the amount of urinary biomarkers of oxidative stress, such as 
allantoin, m-tyrosine, 8-OHdG. A tendency to the reduction of 3-nitrotyrosine was also observed. 
Our study supports an in vivo antioxidant effect of the oral administration of C. longa extract to 
healthy rats. The observation that urinary TMAO levels are increased in the treated compared to 
the control group may be related to the influence of curcumin supplementation on microbiota, as 
recently indicated by other research groups, or on the urinary excretion of this metabolite. 
Urinary levels of taurine and cystine, sulphur containing compounds, were also changed 
suggesting a role for such constituents in the biochemical pathways involved in C. longa extract 
bioactivity and indicating the need for further investigation on curcumin effects.  
In the third chapter, again both 1H-NMR and UPLC-MS measurements were performed in a 
longitudinal study to assess the urinary metabolome changes induced by 49 days 
supplementation of P. cuspidatum to healthy rats. There were significant metabolic effects that 
could be ascribed to treatment or to aging. Our data showed that resveratrol from P. cuspidatum 
induced changes in the endogenous urinary profile, confirming the bioactivity of this antioxidant. 
The measurement of oxidative stress urinary markers, i.e., allantoin and 8-OHdG confirmed the 
in vivo antioxidant effect of this P. cuspidatum. Cortisol derivatives were increased in the treated 
group suggesting a stimulating activity of this extract on steroid metabolism that need further 
investigations in future. Nevertheless, the analysis highlights the potential of NMR and MS 
based metabolomic analysis as a tool for in vivo investigations and the possibility that integrated 
metabolomic studies of other biofluids (i.e., plasma) and tissues could provide a clearer 
metabolic picture in the future with the same antioxidants. 
In chapters 4 and 5, we successfully used an NMR-based metabolomic approach in the origin 
discrimination of Italian and Ecuador honey with different botanical and entomological origins, 
respectively. 
Specifically, two methods were adopted for 82 citrus honey samples (in chapter 2) to distinguish 
clementine from citrus honeys. A simple, direct CDCl3 extraction method was developed that 
results in a better signal-to-ratio as compared to our old reported method with CHCl3 liquid-
liquid extraction. This new method requires less time in sample preparation and maintains all the 
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necessary information in the 1H-NMR spectra. To the best of our knowledge, this is the first 
attempt to discriminate clementine from citrus honeys. Our D2O extraction strategy revealed 
phenylacetic acid and tyrosine as marker compounds in citrus honey whereas higher amounts of 
formic acid characterized clementine honey. In the case of the CDCl3 extraction, 8-
hydroxylinalool and caffeine were found to be higher in the citrus honey whereas, clementine 
honey was characterized by the resonances of a yet unknown compound. 
In chapter 5, a chemometric approach was used in combination with NMR spectrometry to 
discriminate the entomological origin of different honey samples from Ecuador. The study 
included also the distinction of false honey from genuine honey. In total, we received 91 
samples, out of which 8 were false and 83 were genuine honeys produced by different bee 
species. Not surprisingly, we found 5-hydroxymethyl furfural and 2-hydroxyacetyl-furan as main 
indicators of false honey. Sorbic acid and benzoic acid were not present in all false honey, but 
could be used as descriptors of false honey. We found a diacylglyceryl ether as the marker of 
genuine honey. This study also demonstrated that a metabolomic approach based on 1H-NMR 
and associated with PLS-DA and cluster analysis is a very suitable tool to distinguish the 
entomological origin of honeys. The multivariate statistical analysis also revealed yet unknown 
markers of different entomological origins. These preliminary results will be further pursued in 
the future to identify the resonances responsible for discrimination of different honeys.  
In general, in chapter 4 and 5 we proposed that a 1H-NMR-based metabolomic approach for 
origin discrimination of honey could be used as an alternative to the classical method of origin 
assessment through melissopalynological analysis and physical-chemical methods. The proposed 
method of chloroform extraction requires very little sample preparation, is fast, reproducible, 
allows one to obtain a fingerprint of different classes of compounds at the same time, and is more 
objective than melissopalynological analysis. 
 
 
 
 
